rfhg_222695.1

Basic information about the TSS

---

TSS ID: rfhg_222695.1 Species: human Chr: chr20		Start: 58891498 End: 58891510 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3317004,EH38E2125807)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC002722:-30 GeneID: 2778 HGNC/MGI_ID: HGNC:4392 UniProt_ID: Nearer transcript ids and distances: BC108315:-36 ENST00000354359.12:-77 ENST00000371085.8:-77 NM_001309842.2:-77 NM_001077489.4:-77 NM_080426.4:-77 NM_000516.7:-77 NM_001077488.5:-77 BC089157:-87 BC008855:-87 BC104928:87 AK225818:-105 AK026564:-112 ENST00000265620.11:-134 X04408:152 ENST00000468895.6:181 ENST00000371095.7:-196 X04409:205 ENST00000371081.5:206 X07036:206 AB385065:213 EU832170:215 EU832264:215 CU678144:216 CU679149:216 KJ905761:216 HQ448266:216 KJ891258:216 KR710750:216 KR710751:216 KR710752:216 KR710753:216 ENST00000338783.7:217 KU178095:217 KU178096:217 BT009905:217 AF064092:217 AF088184:217 AF493897:217 AF493898:217 BC066923:217 ENST00000682803.1:244 M14631:250 LF350859:251 MA586436:251 AK315860:295 BC022875:329 LQ980482:-438 ENST00000488652.6:471 view more...

Gene_name: GNAS complex locus Gene_symbol: GNAS Gene_synonyms: GNASXL GPSA NESP NESP55 SCG6 SgVI Gene_source: HGNC:4392

TATA-Box annotation

---

Distance to TSS:	83
Nearest PromoterID:	NM_000516
Entrez ID:	2778
Nearest Unigene:	Hs.125898
Nearest Refseq:	NM_000516
Nearest Ensembl:	ENSG00000087460
Gene Name:	GNAS complex locus
Gene Alias:	AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PITA3|POH|SCG6|SgVI
Gene Type:	protein-coding
CpG%:	0.166667
GC%:	0.846154
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GNAS p2@GNAS p3@GNAS p4@GNAS p5@GNAS p6@GNAS p8@GNAS p9@GNAS p10@GNAS
Sample		p1@GNAS	p2@GNAS	p3@GNAS	p4@GNAS	p5@GNAS	p6@GNAS	p8@GNAS	p9@GNAS	p10@GNAS
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	240.19	124.67	143.38	8.38	4.09	20.26	0.78	1.75	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	236.31	131.30	155.18	10.32	4.86	22.26	1.42	1.42	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	219.91	122.30	145.45	5.59	2.12	20.06	1.93	1.74	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	231.61	135.14	153.85	5.20	4.16	25.99	0.83	3.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	251.29	133.63	176.37	9.90	6.52	24.52	0.90	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	205.05	112.60	152.53	8.92	3.10	20.74	1.74	1.74	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	204.37	138.36	156.66	7.41	2.18	25.71	0.65	3.27	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	221.15	99.55	163.26	8.24	4.36	20.59	1.21	2.66	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	246.20	126.95	156.87	8.12	4.06	26.71	0.85	2.35	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	225.47	106.07	207.51	6.96	4.64	21.45	1.16	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	242.14	116.82	203.33	7.28	4.04	31.53	1.62	2.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	218.32	104.08	224.01	8.94	4.07	29.27	1.63	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	127.66	199.72	21.76	21.60	29.18	6.29	2.74	2.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	98.48	124.04	21.50	18.04	19.40	4.36	1.80	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	159.40	177.84	21.52	23.49	32.71	6.37	2.63	1.32	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	127.25	174.79	15.59	19.36	23.64	4.78	2.51	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	117.50	147.42	17.04	22.50	24.46	4.15	2.84	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	108.83	118.11	13.50	26.57	21.93	5.48	2.53	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	102.37	98.10	14.93	20.79	14.40	5.86	2.13	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	92.07	129.38	19.71	17.45	21.36	4.21	1.81	1.35	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	102.91	133.38	20.18	17.11	22.19	4.14	2.27	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	87.69	113.76	18.47	16.57	20.54	3.97	2.24	0.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	108.96	123.96	16.16	20.29	19.26	5.69	2.07	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	130.07	145.36	21.11	19.17	24.75	5.82	2.18	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	126.16	144.22	17.80	21.16	25.54	3.61	3.10	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	117.43	137.37	18.04	20.26	18.36	5.06	1.90	2.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	109.34	100.00	14.29	13.74	12.09	3.30	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	127.07	144.52	20.98	16.97	27.11	6.84	2.59	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	98.69	116.94	21.64	16.80	17.77	4.85	2.42	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	116.36	138.44	22.98	16.11	26.42	5.61	1.63	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	104.67	127.49	17.79	15.70	19.68	3.56	1.67	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	101.01	138.72	16.80	12.31	22.47	6.06	3.13	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	86.52	111.42	17.52	16.25	18.78	5.28	2.11	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	72.08	69.60	21.28	15.17	6.43	3.79	3.46	0.82	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	107.33	151.65	19.82	14.02	25.99	3.37	2.80	2.06	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	125.90	174.76	21.08	16.67	27.59	6.32	2.30	2.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	122.63	145.93	19.82	18.19	23.71	5.31	2.25	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	136.41	124.32	21.56	14.71	24.38	4.43	1.21	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	146.13	144.23	20.53	22.69	28.63	5.40	2.43	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	133.23	146.44	19.93	19.93	25.45	6.00	1.20	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	126.10	128.69	19.06	19.76	23.53	8.70	2.35	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	82.13	96.03	19.18	18.88	10.69	6.59	2.78	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	128.43	183.48	15.18	16.03	28.47	4.22	2.53	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	125.35	161.37	16.96	15.38	26.57	3.85	3.15	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	154.60	185.92	18.47	20.28	31.32	5.42	2.41	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	150.75	167.27	16.98	15.35	31.41	6.28	2.33	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	156.18	180.89	23.27	17.51	31.19	5.28	1.92	1.68	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	140.68	158.56	17.88	14.60	30.70	3.58	2.09	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	159.18	178.33	21.06	14.60	33.75	5.51	0.72	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	117.48	123.74	17.59	12.13	23.05	4.25	1.42	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	127.28	200.03	18.86	11.07	16.60	5.94	1.84	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	163.22	192.35	21.35	10.90	22.46	2.89	4.23	1.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	167.91	27.98	55.97	0.00	13.99	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	157.91	235.63	19.87	13.48	24.84	3.90	2.13	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	162.05	208.77	18.56	14.25	16.90	5.96	1.66	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	81.38	135.91	22.65	15.10	6.71	1.68	10.91	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	69.80	91.39	24.34	4.13	9.64	4.59	2.76	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	162.38	286.84	15.56	14.58	28.20	5.19	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	181.78	297.40	16.38	9.64	41.11	7.71	1.61	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	94.93	103.41	21.06	8.80	10.06	3.77	2.20	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	222.09	265.81	18.33	9.17	38.78	2.12	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	185.62	228.80	14.58	11.22	38.13	2.80	4.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	145.69	191.07	29.46	20.70	15.92	3.18	5.57	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	79.17	107.03	21.07	6.12	13.93	4.42	3.74	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	137.12	238.49	16.25	8.77	46.79	5.52	2.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	242.45	314.16	11.36	9.94	47.92	3.90	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	242.46	210.13	32.33	80.82	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	236.92	205.33	31.59	47.38	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	341.26	317.37	18.53	10.73	36.56	3.90	2.93	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	247.44	224.63	18.35	8.93	29.75	3.97	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	194.21	258.95	22.52	6.57	25.33	5.16	3.75	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	177.85	226.86	16.89	11.26	20.86	2.65	3.31	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	234.79	370.28	15.78	6.81	47.95	5.57	1.86	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	281.59	423.46	16.20	11.01	52.59	7.03	2.45	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	289.84	134.31	43.40	31.04	9.34	11.09	5.23	3.17	0.00
Adipocyte - breast, donor2	11327-117E4	430.42	158.66	31.92	25.51	10.59	7.22	2.25	1.93	0.00
Adipocyte - omental, donor1	11473-119C6	337.28	143.13	40.71	41.48	8.78	11.96	9.67	2.04	0.00
Adipocyte - omental, donor2	11474-119C7	292.27	118.10	33.64	14.20	11.21	14.95	5.98	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	360.71	137.99	32.82	15.07	17.08	10.38	7.03	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	283.27	115.48	38.28	20.42	16.59	8.93	5.74	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	356.24	109.95	34.08	25.29	7.70	16.49	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	206.39	61.42	20.32	18.97	7.23	4.52	3.61	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	207.84	137.80	27.80	28.67	10.95	6.95	3.82	2.95	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	208.09	124.97	34.81	28.55	20.14	8.80	1.96	2.35	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	183.25	120.20	17.24	20.59	21.11	5.15	0.26	2.32	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	262.88	139.39	35.96	26.76	23.70	9.20	1.12	1.95	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	188.69	119.33	29.98	28.21	22.34	8.23	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	681.91	161.83	46.09	36.44	14.80	11.34	2.82	1.69	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	194.62	101.34	17.75	24.85	13.88	8.71	1.94	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	245.80	105.57	30.39	22.39	9.60	5.87	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	343.32	92.92	32.27	25.04	12.80	10.02	2.78	2.23	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	660.02	168.85	39.09	27.03	18.72	7.49	1.25	2.91	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	222.28	100.97	20.60	20.85	16.33	5.02	0.75	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	394.33	115.84	28.14	22.25	13.74	7.20	1.96	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	460.97	137.01	29.84	22.53	15.53	5.18	2.74	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	611.28	91.94	34.70	19.67	11.49	8.62	0.88	0.88	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	520.30	86.42	66.70	12.19	12.91	6.81	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	312.68	164.13	19.17	25.16	16.77	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	672.85	120.90	48.03	34.72	13.85	10.97	2.16	2.16	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	568.99	307.92	45.18	38.49	21.76	15.06	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	613.05	212.43	44.17	41.71	19.31	8.63	1.44	1.23	0.00
Anulus Pulposus Cell, donor1	11248-116E6	221.41	87.76	25.75	59.27	13.85	9.96	4.12	2.98	0.00
Anulus Pulposus Cell, donor2	11463-119B5	186.62	76.90	26.45	22.78	14.94	7.35	5.39	2.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	89.41	39.09	20.22	18.87	12.58	2.25	1.80	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	143.27	49.06	21.27	22.14	9.99	3.47	5.21	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	136.98	111.29	21.40	29.96	14.98	2.14	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	133.02	47.83	19.43	30.19	11.96	2.39	4.18	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	140.38	61.97	35.41	34.15	10.12	1.26	8.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	135.31	85.15	11.22	19.14	9.90	0.66	2.64	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	118.91	44.18	20.14	21.12	8.12	3.57	3.57	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	120.39	50.49	19.42	25.73	8.25	4.37	2.43	2.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	149.06	67.11	22.57	24.94	5.94	2.97	4.75	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	116.00	40.30	18.83	24.86	9.79	4.14	3.77	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	135.70	42.81	24.67	30.48	10.16	7.26	7.26	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	135.41	77.73	17.55	22.57	3.76	1.25	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	221.57	67.71	26.52	36.41	8.57	5.93	3.95	0.99	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	133.75	38.21	30.03	35.48	12.28	1.36	4.09	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	154.26	65.59	22.02	17.34	8.75	6.18	1.81	1.36	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	130.73	40.72	17.68	32.15	7.50	3.75	5.36	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	190.64	66.32	21.16	33.44	12.09	3.40	3.02	1.13	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	169.46	77.51	18.44	27.53	6.41	3.47	3.74	1.34	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	126.81	36.09	14.63	28.29	10.73	0.98	5.85	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	178.63	58.88	20.73	29.69	11.78	4.98	2.99	1.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	130.88	81.65	21.61	26.42	8.41	0.00	3.60	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	92.04	24.78	17.70	21.24	10.62	3.54	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	187.83	63.47	20.41	30.70	11.49	3.43	3.26	1.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	104.87	67.12	12.58	12.58	12.58	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	116.02	50.00	20.39	26.21	11.16	3.88	5.83	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	213.63	58.06	18.59	38.70	8.73	7.59	3.79	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	133.25	86.01	26.65	23.02	7.27	3.63	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	98.05	47.31	27.36	23.37	10.26	5.70	3.99	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	184.06	65.84	20.74	30.78	9.19	5.13	7.70	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	148.66	78.46	21.16	20.65	12.39	3.10	3.87	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	119.65	46.45	17.83	35.19	9.38	2.35	2.35	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	184.25	61.09	18.65	30.55	11.90	7.07	2.57	2.57	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	143.40	76.34	29.96	22.12	7.85	0.71	2.14	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	117.58	41.53	15.21	25.15	5.26	2.34	1.17	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	179.74	78.28	17.16	28.90	12.65	2.11	3.31	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	161.57	112.86	24.95	20.20	16.63	3.56	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	142.91	36.62	20.34	18.82	7.63	3.05	5.09	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	167.84	62.65	20.38	24.70	10.44	2.29	2.80	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	143.59	77.51	18.43	19.06	8.90	2.54	1.91	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	130.32	39.27	24.60	20.28	10.36	3.02	3.02	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	169.35	68.16	19.90	26.88	15.03	4.02	4.02	1.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	119.47	79.45	17.69	21.46	8.41	2.90	2.32	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	136.04	49.13	26.45	33.07	11.34	2.83	7.56	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	180.54	59.84	17.63	24.07	12.38	2.54	3.05	2.03	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	150.56	74.12	11.58	25.48	4.63	4.63	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	86.62	35.91	23.24	33.80	14.79	6.34	6.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	191.47	50.60	21.01	25.73	12.44	3.86	3.65	1.72	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	116.72	84.83	19.25	18.65	7.22	4.21	3.01	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	107.16	35.72	23.33	17.50	11.66	3.64	3.64	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	206.89	52.64	22.30	32.64	10.57	5.29	4.83	1.38	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	170.87	81.61	22.95	2.55	5.10	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	147.71	50.08	22.37	15.76	6.61	3.81	2.54	1.53	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	204.17	60.07	19.61	32.62	10.94	5.78	1.65	1.24	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	161.57	87.82	21.42	26.32	7.04	6.12	2.14	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	135.76	49.24	23.90	19.12	11.95	1.43	3.35	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	176.73	60.09	20.84	27.72	11.75	3.33	2.88	2.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	149.53	82.39	16.78	32.04	12.21	3.05	9.15	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	109.12	39.33	24.37	16.62	11.63	3.88	2.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	158.61	70.44	17.74	28.07	13.24	4.24	3.18	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	163.19	77.05	24.35	23.26	8.36	3.27	1.82	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	486.60	52.44	38.56	46.42	13.39	12.53	3.19	3.56	0.37
Astrocyte - cerebellum, donor2	11580-120F5	370.05	122.21	31.15	25.16	26.36	8.90	1.71	2.91	0.00
Astrocyte - cerebellum, donor3	11661-122F5	303.08	177.45	31.04	45.72	20.14	10.28	2.31	2.52	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	345.45	113.99	58.56	58.91	16.38	11.50	5.58	3.83	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	351.05	207.23	38.66	41.74	11.97	8.90	2.59	1.62	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	456.28	268.49	82.34	48.78	22.37	15.81	2.68	3.28	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	265.27	249.21	48.86	23.85	25.00	13.07	1.61	2.18	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	295.79	256.20	50.86	28.19	19.92	13.41	1.13	2.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	248.42	220.31	45.52	25.38	14.91	12.29	0.91	2.16	0.00
Basophils, donor1	12241-129G9	82.12	83.69	85.78	9.15	12.03	9.94	0.26	1.57	0.26
Basophils, donor2	12242-129H1	68.55	99.58	97.78	8.66	14.43	12.63	1.44	1.80	0.00
Basophils, donor3	12243-129H2	144.20	100.84	109.37	12.49	21.31	11.91	0.44	2.79	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	405.76	87.10	40.75	13.15	13.15	8.84	1.72	1.29	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	369.86	84.12	33.37	12.80	20.12	5.94	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	164.99	215.21	71.74	7.17	7.17	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	166.96	64.02	19.46	5.02	9.41	3.14	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	250.37	114.16	25.79	11.44	22.04	5.61	0.62	0.62	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	230.29	109.62	27.87	11.28	21.19	5.53	1.61	0.92	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	302.49	118.94	34.73	14.04	11.34	7.74	1.80	1.62	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	238.57	100.89	189.21	23.60	10.92	31.02	8.35	7.94	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	150.69	91.76	187.72	18.63	9.08	39.13	2.33	4.89	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	176.52	148.38	115.12	40.93	14.39	21.74	2.56	8.95	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	372.31	124.10	113.76	41.37	31.03	0.00	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	55.79	82.28	98.06	8.45	15.78	12.40	0.56	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	82.22	147.37	97.25	12.81	22.27	10.58	1.30	1.30	0.00
CD14+ Monocytes, donor3	11381-118B4	83.42	148.63	115.70	8.12	23.93	9.22	0.66	2.20	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	185.39	111.52	55.48	30.85	31.70	9.62	0.57	2.83	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	200.53	142.53	68.23	28.81	29.19	9.86	0.38	2.65	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	197.90	140.37	60.49	31.89	44.71	7.89	0.33	3.62	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	61.58	102.63	44.38	6.94	21.97	5.78	0.29	0.87	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	68.19	93.24	44.05	7.85	25.35	5.43	0.00	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	76.75	113.00	59.93	6.63	26.30	5.21	0.00	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	47.04	85.04	41.01	4.52	17.41	4.85	0.00	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	57.69	85.29	52.44	5.80	19.60	4.97	0.00	2.21	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	71.40	74.87	64.96	4.71	15.62	8.93	0.00	1.49	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	45.03	66.38	44.45	4.50	14.49	3.72	0.00	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	43.98	79.41	57.51	4.27	14.96	6.05	0.36	1.25	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	72.91	65.29	81.18	6.53	11.10	5.66	0.65	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	48.93	60.40	51.51	5.38	9.13	4.92	0.70	1.17	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	67.06	69.17	57.56	6.86	14.26	5.28	0.53	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	64.34	57.69	65.45	4.44	5.55	7.77	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	50.57	79.88	38.97	5.65	17.25	5.35	0.15	1.64	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	47.49	68.05	45.30	4.79	17.56	3.99	0.00	1.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	47.05	47.89	55.38	4.79	9.99	3.54	0.83	1.04	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	51.02	82.13	51.25	6.41	15.79	4.35	0.23	2.06	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	49.09	43.43	51.57	6.79	10.86	5.66	0.68	1.36	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	58.05	61.54	52.81	3.49	8.73	5.67	0.00	2.18	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	48.42	99.80	46.00	6.46	19.64	3.50	0.54	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	59.84	109.39	61.58	7.15	19.71	7.15	0.35	1.40	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	65.23	119.51	77.43	7.57	21.46	8.42	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	38.21	64.48	41.52	6.25	11.76	6.61	0.00	0.92	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	51.43	68.69	39.81	4.93	13.39	5.99	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	48.26	75.46	60.11	4.83	9.65	7.46	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	42.55	69.58	46.56	9.24	17.09	6.10	0.17	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	62.07	86.97	63.93	7.06	17.84	5.95	0.00	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	70.70	68.76	95.70	8.41	11.21	7.98	0.43	1.94	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	84.35	92.13	55.69	6.14	15.15	5.32	0.82	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	47.75	47.06	52.39	5.56	5.56	4.64	0.00	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	46.63	43.85	59.16	3.48	4.41	6.73	0.46	1.39	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	73.24	84.79	97.21	8.28	9.59	10.03	0.00	2.83	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	88.01	90.55	120.58	6.93	9.93	10.63	0.46	3.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	84.48	74.95	94.88	6.50	12.13	8.66	0.22	3.68	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	57.93	105.11	123.33	12.77	17.91	9.81	0.16	3.27	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	63.22	87.32	138.14	9.95	18.51	13.45	0.87	2.62	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	75.36	100.56	134.00	8.25	20.51	11.82	0.22	2.68	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	108.19	83.70	130.14	3.57	7.66	11.48	0.51	4.34	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	162.26	103.42	149.52	6.59	7.90	13.83	1.10	3.07	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	132.01	93.69	123.38	4.63	10.32	15.79	0.21	1.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	123.97	105.68	136.16	14.23	20.32	14.23	6.10	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	103.73	121.36	110.51	25.76	21.70	15.59	0.68	3.39	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	114.95	97.35	135.66	23.82	20.71	11.39	2.07	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	109.81	126.86	114.60	14.39	21.32	14.39	1.07	2.13	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	105.61	149.56	167.79	30.56	27.34	17.69	2.68	3.75	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	103.89	114.42	93.36	20.36	17.55	16.85	2.81	2.81	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	112.16	141.97	130.20	24.31	22.75	15.69	1.57	3.92	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	104.14	110.74	147.65	26.37	19.77	18.46	2.64	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	190.68	228.49	180.82	23.84	32.88	21.37	3.29	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	161.04	179.91	106.64	15.96	29.02	6.53	1.45	2.90	0.00
CD19+ B Cells, donor3	11705-123B4	168.61	189.81	136.81	24.23	24.23	14.14	1.51	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	220.62	128.09	309.10	17.37	12.12	36.77	0.40	5.25	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	196.55	92.68	276.45	13.98	9.19	43.54	0.00	5.19	0.00
CD34+ Progenitors, donor1	11545-120B6	107.43	43.17	68.28	24.10	5.02	13.05	4.02	4.02	0.00
CD34+ Progenitors, donor2	11625-122B5	164.05	33.15	87.64	15.73	6.18	14.61	6.74	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	154.81	108.59	98.45	51.10	17.28	22.17	4.13	9.02	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	147.02	123.11	97.86	34.50	14.21	18.26	5.41	5.19	0.00
CD4+ T Cells, donor1	11225-116C1	131.40	142.47	156.39	10.35	26.78	15.71	1.79	2.50	0.00
CD4+ T Cells, donor2	11306-117C1	167.79	308.02	142.07	11.63	29.39	9.19	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	151.89	231.79	199.77	8.23	30.50	14.64	1.22	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.60	62.02	92.14	11.74	24.50	12.00	0.77	1.79	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	84.90	100.39	99.72	14.37	20.66	10.78	0.90	2.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	72.15	104.06	99.17	13.51	20.41	12.36	0.86	1.15	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	79.65	130.85	151.71	9.01	20.39	15.17	1.42	2.37	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.02	99.03	159.43	21.07	21.07	16.15	2.11	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	171.40	178.00	9.89	39.55	16.48	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	82.23	80.35	92.35	15.61	18.21	10.84	1.88	1.73	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	82.70	149.13	87.44	10.00	25.76	12.20	0.34	1.19	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	66.42	126.71	82.38	10.48	25.31	10.80	0.32	1.61	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	75.31	68.59	129.11	8.07	15.24	17.48	0.00	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	72.67	78.26	155.48	5.94	15.37	12.58	1.05	3.49	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	69.96	77.88	120.55	7.92	13.20	13.64	0.44	1.76	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	117.22	95.71	113.00	10.96	14.76	10.96	0.84	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	129.23	225.64	94.95	13.51	31.58	12.88	0.62	2.70	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	109.26	224.20	108.59	10.02	32.08	14.03	0.00	2.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	109.32	159.63	140.32	10.33	19.58	13.05	0.54	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	101.83	147.39	138.27	6.97	23.05	14.47	2.14	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	175.74	145.25	7.17	32.28	7.17	7.17	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	130.91	111.81	139.81	20.40	23.73	17.06	1.11	2.60	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	105.93	112.21	117.41	14.30	26.43	17.33	0.87	2.60	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	94.78	139.12	118.53	13.03	33.62	18.28	0.63	4.62	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	78.37	104.66	155.73	5.06	14.66	16.18	0.51	2.53	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	74.09	100.51	146.87	7.80	27.29	17.76	0.87	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	82.37	115.93	135.54	10.02	17.43	12.64	0.87	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	109.86	143.02	136.09	17.32	19.30	19.79	2.97	6.93	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	101.55	117.24	137.55	22.16	28.62	15.69	2.77	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	87.94	142.37	108.87	22.33	32.10	11.17	1.40	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	90.28	42.09	132.37	8.58	18.83	15.23	1.94	2.49	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	99.38	56.69	165.88	13.99	21.84	21.84	1.47	3.19	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	80.08	103.18	150.92	13.86	15.40	9.24	0.00	6.16	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	102.06	139.31	125.34	16.83	30.08	13.61	0.36	3.22	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	119.11	132.96	20.77	23.54	22.16	2.77	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	178.43	146.02	175.81	15.39	27.50	18.99	0.65	2.62	0.00
CD8+ T Cells, donor2	11307-117C2	143.42	234.27	154.68	13.14	16.89	16.14	1.13	3.38	0.00
CD8+ T Cells, donor3	11383-118B6	167.15	273.95	197.70	13.63	30.30	19.19	2.27	2.52	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	224.34	83.96	95.66	13.53	16.52	13.76	7.57	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	183.09	76.69	94.90	12.22	11.98	12.22	5.51	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	147.19	69.49	74.69	12.31	6.57	10.12	6.84	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	133.89	55.54	86.46	10.81	8.11	11.11	8.41	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	202.07	64.80	97.67	11.52	9.36	13.20	7.92	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	191.46	64.58	98.23	7.28	12.05	8.64	7.50	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	212.07	69.53	80.83	8.69	8.26	12.60	7.60	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	206.62	71.59	78.96	9.21	11.05	9.48	7.11	1.84	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	215.05	75.75	80.67	11.02	7.97	7.97	7.04	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	264.44	70.34	92.68	7.85	10.57	11.47	6.94	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	245.48	83.96	88.02	9.30	8.42	10.75	4.94	1.74	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	215.55	85.26	119.10	8.53	15.45	12.79	4.26	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	326.56	120.82	108.56	11.38	14.45	10.94	6.13	1.75	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	342.03	124.33	109.30	13.66	11.39	9.11	8.65	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	460.20	184.23	108.15	14.92	16.41	5.97	6.71	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	212.13	78.51	111.65	9.00	14.41	13.33	6.84	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	213.49	79.41	106.17	10.93	16.98	10.36	5.18	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	171.82	78.02	95.46	9.19	11.55	10.13	8.01	2.12	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	135.00	60.85	98.56	12.99	7.61	8.56	6.97	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	154.40	62.13	105.49	12.30	11.99	7.69	6.77	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	154.52	62.19	92.65	8.01	8.66	8.01	3.85	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	239.81	77.26	84.91	9.18	6.88	12.24	8.03	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	236.07	80.00	102.86	9.06	10.25	11.43	5.52	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	231.46	71.86	79.42	5.29	3.78	12.10	4.54	3.78	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	484.99	123.66	177.45	20.88	14.45	12.04	7.23	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	442.04	151.78	137.09	7.69	11.19	20.28	6.29	4.90	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	407.71	160.28	191.33	16.03	17.03	21.04	7.01	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	524.56	380.17	56.66	67.63	18.28	5.48	1.83	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	242.10	98.32	25.20	30.14	13.34	5.93	2.96	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	340.53	106.60	44.93	43.15	12.52	15.15	4.63	3.37	0.00
Chondrocyte - de diff, donor1	11261-116G1	171.25	67.25	21.49	14.91	17.33	7.97	6.24	2.43	0.00
Chondrocyte - de diff, donor2	11338-117F6	173.07	66.46	17.77	19.90	14.57	6.04	4.26	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	166.57	136.08	22.98	36.07	12.86	4.66	5.23	2.96	0.00
Chondrocyte - re diff, donor2	11339-117F7	211.28	78.78	44.76	25.07	18.80	8.95	7.16	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	281.06	253.56	60.26	26.69	27.50	14.56	6.07	2.02	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	235.71	122.33	28.92	53.02	12.85	6.31	4.25	1.95	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	198.80	138.31	20.09	40.19	13.25	4.49	2.35	2.99	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	290.72	154.61	27.79	35.49	16.37	6.99	2.57	2.21	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	189.82	109.58	48.69	38.61	13.30	6.88	1.74	2.66	1.19
Corneal Epithelial Cells, donor1	11526-119I5	423.99	82.34	30.96	19.98	16.47	7.03	1.10	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	268.47	94.42	43.23	19.34	6.83	4.55	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	299.34	115.29	32.98	16.36	14.32	7.41	0.26	1.79	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	117.05	41.60	55.97	9.41	9.74	8.25	0.00	1.98	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	123.96	47.31	55.20	11.04	10.41	9.15	0.32	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	110.42	48.31	79.37	6.90	6.90	20.70	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	162.20	76.89	63.17	10.69	14.69	8.53	0.43	1.51	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	335.49	184.14	137.34	52.27	17.42	11.96	4.44	2.05	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	237.64	186.07	124.05	62.02	13.71	12.40	1.31	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	240.04	65.82	122.92	37.75	9.68	11.13	4.84	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	233.81	91.39	26.35	29.18	10.67	3.84	0.50	1.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	292.80	134.96	17.02	28.17	21.12	3.52	2.35	2.35	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	395.35	95.87	48.36	32.80	15.84	7.35	1.13	1.13	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	287.81	234.34	31.45	41.28	12.19	6.68	0.79	2.75	0.00
Endothelial Cells - Artery, donor1	11264-116G4	341.49	144.86	18.62	37.52	17.16	4.36	1.16	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	372.68	142.11	32.70	40.94	12.00	5.41	2.82	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	270.68	129.55	21.39	27.87	14.90	3.51	1.05	1.05	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	241.82	88.00	26.82	27.71	11.08	6.21	1.11	3.10	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	251.32	98.58	25.86	23.73	10.95	4.56	1.52	2.13	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	280.78	86.83	31.29	21.99	10.99	5.64	0.85	1.97	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	285.55	45.16	21.39	29.71	13.67	5.94	3.57	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	220.24	48.94	18.74	26.03	7.81	0.52	3.12	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	250.68	131.72	15.88	41.40	18.43	3.83	2.41	1.42	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	242.47	35.61	21.61	22.81	9.20	4.80	4.00	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	338.58	171.39	24.11	27.78	13.10	3.14	1.57	2.10	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	317.20	142.88	31.06	49.95	13.92	8.95	3.73	2.48	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	278.31	209.66	22.38	29.55	24.33	8.69	2.39	1.96	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	323.64	226.42	28.33	30.90	19.66	4.76	1.22	1.22	0.00
Endothelial Cells - Vein, donor1	11267-116G7	295.75	117.16	17.06	18.20	23.89	4.55	3.41	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	355.54	95.00	12.57	34.93	13.27	4.19	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	259.22	175.53	19.78	37.21	18.06	4.08	1.41	0.79	0.00
Eosinophils, donor1	12244-129H3	60.99	106.73	45.74	15.25	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	105.62	169.98	80.86	11.55	46.21	3.30	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	71.34	146.24	103.44	17.83	42.80	14.27	3.57	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	349.63	74.52	31.27	13.68	9.77	6.60	1.22	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	380.67	110.25	87.37	0.00	12.48	16.64	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	81.34	81.34	16.27	16.27	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	270.12	269.30	27.50	31.20	23.40	4.93	5.75	2.87	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	215.69	93.50	15.22	14.01	8.98	2.74	2.30	0.77	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	338.56	177.46	30.88	23.29	17.23	9.64	2.06	3.25	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	327.21	94.72	36.63	35.41	10.43	7.76	4.49	2.43	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	117.09	43.67	14.47	18.29	2.87	4.50	6.55	1.23	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	342.46	174.45	27.95	36.60	14.66	6.01	4.96	2.11	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	82.21	24.24	12.91	9.75	5.01	5.01	4.22	1.05	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	282.37	153.14	36.87	29.90	24.25	8.97	2.66	1.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	329.79	151.06	24.50	35.38	15.88	3.18	4.08	2.27	0.00
Fibroblast - Cardiac, donor2	11345-117G4	451.74	59.88	22.74	27.29	16.67	2.27	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	364.32	145.73	22.40	23.34	14.67	4.10	2.21	1.89	0.00
Fibroblast - Cardiac, donor4	11452-119A3	233.09	74.56	44.86	39.10	16.97	16.06	4.55	3.64	0.00
Fibroblast - Cardiac, donor5	11456-119A7	246.83	111.93	21.32	19.92	19.80	5.84	3.43	1.78	0.25
Fibroblast - Cardiac, donor6	11460-119B2	199.04	67.00	21.53	20.62	11.67	5.00	1.97	1.52	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	437.21	55.34	56.28	34.70	17.02	12.60	7.77	4.29	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	310.63	169.12	29.77	47.46	17.69	6.04	7.77	3.02	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	578.59	117.18	48.34	27.83	20.51	14.65	7.32	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	581.67	164.21	48.90	59.74	20.76	13.61	2.77	3.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	416.21	151.29	53.93	81.07	11.36	14.76	7.97	6.44	0.00
Fibroblast - Dermal, donor1	11269-116G9	207.55	90.16	20.90	25.83	17.37	4.23	1.88	1.17	0.00
Fibroblast - Dermal, donor2	11346-117G5	198.11	47.17	10.85	20.28	5.66	3.30	2.36	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	160.17	129.11	18.50	32.28	17.29	6.17	1.93	2.18	0.00
Fibroblast - Dermal, donor4	11450-119A1	205.40	69.86	22.38	16.05	16.73	3.96	0.79	1.58	0.00
Fibroblast - Dermal, donor5	11454-119A5	244.06	87.58	34.19	17.97	17.27	5.58	1.92	1.57	0.00
Fibroblast - Dermal, donor6	11458-119A9	243.64	88.36	31.19	16.89	19.00	5.85	1.46	1.62	0.00
Fibroblast - Gingival, donor1	11237-116D4	145.55	48.31	20.20	28.94	12.29	6.66	2.92	1.87	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	393.52	250.47	33.80	41.92	19.91	7.07	3.14	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	198.86	111.75	21.74	28.33	10.54	7.12	1.84	1.98	0.00
Fibroblast - Gingival, donor3	11394-118C8	216.39	144.45	28.43	42.25	23.40	6.96	3.29	2.51	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	241.02	102.85	12.47	66.49	27.01	2.08	5.19	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	226.77	191.89	14.80	43.52	21.85	6.70	1.94	2.64	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	227.45	112.71	18.71	28.22	14.03	4.99	1.09	1.56	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	181.07	90.74	15.69	26.91	8.25	3.65	1.76	1.76	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	817.62	526.50	21.88	49.76	63.52	4.94	2.12	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	274.94	158.53	23.40	28.23	16.38	4.83	2.63	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	229.89	88.90	33.68	30.68	9.82	7.91	1.91	1.64	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	315.92	108.60	34.11	28.19	14.48	6.14	1.97	1.21	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	310.65	333.98	36.54	48.13	22.60	8.95	2.93	2.79	0.00
Fibroblast - Lung, donor1	11270-116H1	191.67	96.51	12.23	27.19	27.19	4.08	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	185.03	89.53	19.40	34.32	1.49	1.49	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	205.13	151.95	22.16	43.47	19.84	5.49	2.32	1.90	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	347.37	49.98	40.82	26.66	17.49	12.50	1.67	3.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	186.02	95.11	30.77	19.58	25.18	16.78	5.59	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	172.12	101.04	15.11	26.87	9.80	3.36	0.28	1.12	0.00
Fibroblast - Mammary, donor1	11540-120B1	415.71	131.53	35.73	49.53	25.17	8.12	3.25	3.25	0.00
Fibroblast - Mammary, donor2	11620-122A9	215.69	167.76	19.97	51.92	35.95	11.98	0.00	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	285.90	184.64	11.91	41.69	35.74	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	254.88	86.90	30.84	39.57	8.34	4.46	1.94	3.10	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	285.62	176.10	28.52	34.58	19.57	6.22	2.43	2.12	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	171.05	45.59	18.67	24.17	8.26	5.81	1.22	2.14	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	378.57	181.65	17.94	43.12	27.48	4.96	1.53	2.29	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	301.04	171.44	22.41	44.28	22.14	6.48	4.32	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	232.99	213.62	20.06	42.56	30.04	6.49	1.39	0.81	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	339.34	108.43	26.09	34.71	8.95	5.75	3.54	1.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	454.74	111.15	42.06	40.23	18.69	11.18	0.81	3.05	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	302.03	153.02	32.07	44.10	14.70	6.68	3.34	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	313.92	140.75	25.30	41.91	15.02	7.51	1.19	1.58	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	160.54	36.91	24.01	14.29	4.37	3.97	2.78	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	376.91	117.76	47.78	37.83	15.28	9.95	5.68	2.84	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	302.53	101.30	56.56	35.08	12.42	11.83	5.12	1.97	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	173.59	42.72	40.01	14.14	5.72	7.82	2.71	2.11	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	288.34	50.31	114.21	32.60	13.17	23.64	5.94	4.75	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	181.20	43.78	23.79	17.21	6.58	5.31	2.53	1.77	0.25
Fibroblast - skin normal, donor1	11553-120C5	522.75	129.46	60.38	37.90	16.57	10.01	5.91	2.13	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	161.41	60.35	22.46	18.45	6.82	6.22	1.40	1.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	487.74	63.69	82.48	28.23	13.66	13.06	4.82	2.71	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	149.31	50.47	25.99	18.13	7.56	3.63	5.44	1.81	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	275.79	136.53	46.81	49.04	12.01	6.96	6.46	1.66	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	266.00	46.33	52.31	39.49	12.31	12.82	11.97	4.44	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	480.17	55.51	30.87	15.76	6.90	7.88	2.30	3.61	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	550.82	72.01	80.64	30.47	15.13	13.42	4.15	2.66	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	447.51	97.16	45.04	36.60	14.84	7.42	1.52	1.35	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	300.47	158.70	53.32	18.82	13.96	8.94	3.76	2.04	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	487.52	221.60	66.48	66.48	22.16	0.00	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	109.81	207.42	39.22	3.49	22.66	4.36	0.00	4.36	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	178.38	62.58	27.22	16.12	7.80	4.68	1.56	1.73	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	243.85	84.84	29.15	22.64	12.49	9.37	1.82	1.82	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	223.32	62.60	38.33	13.80	12.26	8.69	0.51	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	437.13	245.74	166.12	27.56	18.37	19.90	3.06	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	345.20	188.87	151.22	17.87	7.66	14.68	7.02	4.47	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	161.74	202.54	141.78	11.98	9.70	13.12	3.42	2.85	19.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	484.78	995.48	154.98	48.26	61.77	18.75	4.41	2.48	9.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	467.38	559.86	74.89	27.17	27.86	8.90	5.02	2.51	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	327.31	433.31	111.75	20.41	29.32	18.23	1.59	4.36	20.41
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	513.07	1065.80	145.38	50.75	55.25	14.54	3.44	2.64	8.72
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	677.08	643.16	56.10	34.57	49.57	4.57	2.94	2.94	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	120.73	170.70	295.41	11.94	6.19	26.53	2.21	3.54	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	130.30	121.54	181.74	26.99	7.77	13.57	2.69	3.67	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	192.23	151.34	154.05	21.55	9.36	17.12	2.71	3.69	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	158.22	127.60	106.64	19.88	4.84	13.70	1.88	4.30	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	199.34	164.16	177.66	22.18	9.29	13.63	1.98	2.97	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	126.52	119.46	115.45	14.95	8.44	11.77	2.21	2.08	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	129.50	113.44	51.64	16.06	7.12	9.96	1.42	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	272.45	250.08	117.51	23.96	12.78	17.57	2.97	3.65	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	189.34	178.13	86.82	27.40	11.96	8.47	2.74	1.74	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	200.00	210.27	50.93	19.89	20.98	10.93	2.84	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	306.71	279.23	148.04	34.57	11.23	24.23	4.14	3.55	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	208.71	203.94	144.02	34.18	7.79	16.05	2.86	3.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	247.55	222.53	89.37	24.58	14.52	14.52	3.57	2.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	428.47	306.08	169.78	44.56	9.07	25.20	3.23	4.64	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	300.10	202.04	181.18	41.56	8.65	13.91	5.60	4.07	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	402.93	170.52	143.74	35.65	7.09	22.97	4.70	5.41	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	658.05	296.46	354.31	64.31	9.57	50.57	8.74	11.97	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	687.89	232.43	330.62	54.31	11.95	51.06	7.86	10.93	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	346.35	255.28	208.36	43.38	10.62	23.02	3.43	5.31	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	376.05	185.44	194.26	43.10	8.15	27.12	4.16	5.91	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	419.39	126.80	199.69	35.12	6.74	31.85	4.29	5.31	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	478.84	345.77	226.73	35.69	11.35	27.85	4.75	7.63	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	393.38	282.35	375.16	46.46	8.42	31.82	4.73	8.99	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	373.72	254.65	170.43	30.85	9.67	25.68	3.67	6.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	506.11	399.64	229.25	36.37	13.89	29.10	6.39	6.61	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	430.23	334.29	321.38	41.45	7.99	32.22	6.40	8.73	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	358.87	252.38	161.12	30.80	9.56	23.67	2.43	4.70	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	412.12	479.47	209.75	39.45	11.55	27.90	4.81	4.17	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	426.11	289.38	228.83	38.94	9.10	21.79	4.74	5.59	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	369.82	294.84	156.28	30.05	12.02	24.04	4.27	4.11	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	552.83	439.71	189.14	29.19	10.03	25.54	3.04	4.26	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	438.96	268.66	250.47	35.02	7.53	26.13	3.55	5.65	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	354.58	307.60	166.42	32.71	11.86	27.22	3.73	5.27	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	455.05	313.93	162.72	31.98	10.10	23.29	3.37	4.21	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	481.54	260.35	139.53	35.28	11.11	14.91	2.13	5.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	382.12	260.18	90.65	31.82	11.23	15.24	2.67	5.35	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	455.50	218.80	109.55	28.00	8.11	16.37	2.30	3.67	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	403.25	231.22	163.86	30.96	7.64	14.77	2.59	4.92	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	476.00	365.95	132.28	33.07	18.70	23.04	3.80	4.61	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	662.93	299.94	201.31	33.55	9.22	28.57	5.35	6.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	818.26	337.74	222.60	39.26	7.02	36.41	5.70	6.36	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	793.40	761.66	214.22	50.58	23.80	37.69	9.92	10.91	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	708.10	342.05	160.93	44.32	9.50	25.59	3.43	4.88	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	565.73	314.54	147.48	37.73	12.31	26.43	3.23	4.24	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	707.07	246.79	247.30	69.64	15.76	55.66	17.54	10.42	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	110.48	44.99	193.88	15.73	6.97	21.90	4.78	5.37	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	86.90	106.62	175.80	19.88	6.93	14.02	1.85	3.08	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	104.34	135.84	276.60	27.00	7.77	20.87	3.89	4.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	248.47	124.86	241.27	12.52	6.57	34.42	3.44	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	228.30	115.85	193.83	11.02	7.06	29.10	4.80	6.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	176.64	80.25	121.76	17.53	7.84	11.99	3.69	3.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	334.10	183.14	197.98	12.37	27.22	29.70	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	349.68	150.86	176.38	22.05	11.99	27.08	4.25	4.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	296.83	174.89	162.05	20.86	6.42	40.11	6.42	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	514.69	262.56	236.48	22.60	5.22	50.43	3.48	10.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	417.59	176.08	216.44	10.42	10.74	29.62	2.93	4.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	323.68	145.37	202.19	14.82	9.06	25.94	4.12	5.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	526.50	389.88	253.25	29.99	29.99	43.32	3.33	19.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	418.07	192.68	230.15	21.53	9.79	38.87	3.36	8.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	454.31	192.51	232.71	17.00	10.79	28.76	4.25	4.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	496.59	282.69	301.98	16.78	26.84	45.30	1.68	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	551.85	218.83	390.27	24.81	13.68	61.71	2.54	19.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	434.43	178.66	308.75	20.72	10.53	42.12	2.72	7.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	384.22	175.40	329.93	18.79	10.44	56.38	6.26	8.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	490.80	268.02	660.32	27.49	9.16	77.31	5.73	27.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	445.45	202.75	428.29	31.08	11.25	56.83	5.33	14.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	616.67	299.86	350.69	20.33	25.41	44.05	0.00	10.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	595.63	216.63	359.95	26.51	8.28	55.09	4.56	14.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	529.76	214.25	410.78	23.93	10.59	56.61	2.99	14.50	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	790.27	310.84	279.23	21.07	21.07	52.68	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	432.46	188.75	333.67	27.29	11.15	46.13	3.46	13.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	444.95	187.11	331.19	25.10	12.06	45.31	2.93	10.11	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	529.05	334.42	374.55	25.42	22.07	46.82	2.68	10.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	442.67	209.97	455.39	33.90	10.79	60.10	5.01	10.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	454.63	215.67	467.29	30.47	10.95	59.91	5.48	16.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	596.35	444.78	439.81	37.27	19.88	69.57	0.00	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	367.57	372.29	517.15	24.06	23.59	60.87	4.25	10.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	450.21	274.59	530.47	39.83	14.48	65.18	4.22	9.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	554.97	389.65	457.30	27.98	18.82	66.64	4.58	14.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	402.03	279.98	397.24	29.51	17.55	51.45	6.78	8.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	382.84	217.57	517.53	26.64	9.87	64.63	2.96	14.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	325.80	348.23	528.84	21.25	9.44	63.74	2.36	10.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	351.82	277.14	420.08	28.01	15.75	57.76	7.58	11.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	365.59	261.13	558.70	34.23	14.92	54.42	3.95	12.73	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	289.06	266.18	337.38	31.36	5.93	31.36	1.70	7.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	467.38	210.11	228.02	27.46	8.95	21.49	5.97	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	464.87	180.03	269.31	25.23	7.76	41.73	7.76	5.34	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	401.74	128.97	18.26	23.97	14.84	4.57	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	486.09	181.71	32.43	48.65	20.38	4.16	3.33	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	276.62	183.29	17.99	35.98	15.74	2.25	1.12	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	233.43	85.32	19.98	26.96	7.29	6.03	5.39	2.22	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	266.10	74.36	18.80	35.93	4.18	5.43	6.27	2.92	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	306.93	116.27	215.49	18.22	9.40	37.60	3.25	7.66	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	380.98	137.74	237.84	17.72	11.14	33.93	2.36	6.25	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	368.78	109.20	244.34	17.97	10.24	37.77	2.73	5.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	301.91	124.50	217.09	17.49	8.85	36.73	3.72	7.65	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	364.92	128.09	250.37	20.85	11.18	38.68	1.93	7.74	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	309.79	106.35	231.43	21.74	6.46	35.74	3.44	7.32	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	309.10	129.15	253.43	18.81	10.34	34.75	2.74	8.84	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	311.02	121.46	239.31	21.79	7.03	33.97	3.95	5.49	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	340.24	117.90	256.62	17.62	10.25	33.96	2.88	9.29	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	316.75	130.95	25.74	19.59	27.42	6.16	1.68	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	345.80	183.94	23.37	29.43	25.53	6.49	0.43	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	97.82	92.53	7.93	21.15	2.64	2.64	7.93	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	593.98	126.98	35.62	44.80	25.04	13.05	1.76	4.59	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	557.23	188.17	39.96	59.57	20.34	3.63	2.91	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	293.55	82.87	19.93	19.76	8.22	5.25	1.57	1.57	0.00
Hepatocyte, donor1	11523-119I2	129.53	93.22	25.42	23.00	6.05	1.21	0.00	6.05	0.00
Hepatocyte, donor2	11603-120I1	145.44	132.51	25.86	23.70	11.85	0.00	3.23	1.08	0.00
Hepatocyte, donor3	11684-122I1	150.93	124.55	23.31	16.57	20.25	1.84	1.23	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	440.56	428.16	482.99	28.07	25.45	54.83	13.05	11.75	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	465.44	208.86	0.00	52.61	13.46	0.00	7.34	0.00	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	237.50	63.12	17.15	34.85	9.33	6.72	2.47	2.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	44.57	22.29	9.55	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	33.38	13.35	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	108.33	54.17	0.00	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	83.06	53.99	24.92	9.69	5.54	4.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	107.61	40.04	52.56	7.51	0.00	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	83.08	35.60	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	82.01	76.89	43.57	5.13	7.69	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	118.84	36.57	13.71	4.57	4.57	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	77.97	87.71	37.36	8.12	14.62	1.62	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	78.36	40.02	26.68	1.67	8.34	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	76.24	61.72	21.78	7.26	7.26	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	80.73	71.47	25.15	5.29	3.97	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	102.00	35.48	28.82	4.43	8.87	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	31.43	20.95	10.48	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	66.14	46.61	22.68	3.15	5.04	2.52	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	95.89	60.32	29.39	9.28	10.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	73.17	29.27	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	80.75	64.60	30.36	6.46	5.81	5.17	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	77.28	66.01	22.54	4.83	16.10	6.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	119.48	0.00	0.00	11.95	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	68.45	55.41	26.89	7.33	6.52	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	81.02	38.62	29.81	5.04	2.10	5.04	0.00	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	129.35	143.72	57.49	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	78.76	45.01	33.75	4.82	8.84	4.82	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	82.17	57.24	22.16	4.62	10.16	4.62	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	135.73	60.32	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	85.91	64.20	34.93	8.02	5.19	3.30	0.94	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	79.81	39.91	25.40	3.63	6.35	1.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	103.20	44.23	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	74.25	55.96	43.04	6.46	6.46	3.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	88.93	62.25	24.14	8.89	8.89	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	164.30	16.43	0.00	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	66.32	33.16	27.42	7.01	5.10	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	78.37	41.92	20.05	3.65	12.76	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	79.02	0.00	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	62.12	55.70	32.13	5.00	3.57	2.14	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	56.41	33.18	23.23	0.00	6.64	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	145.94	83.39	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	85.19	64.20	28.71	8.64	8.03	4.01	0.93	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	75.51	40.39	19.32	7.02	8.78	1.76	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	34.57	40.86	6.29	6.29	12.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	63.98	57.72	26.42	6.95	7.65	4.17	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	108.44	59.75	22.13	4.43	8.85	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	58.36	29.18	0.00	22.69	3.24	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	74.99	71.50	30.52	5.23	6.10	2.62	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	74.24	69.74	31.50	11.25	9.00	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	66.21	38.33	34.85	6.97	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	49.07	61.87	27.74	7.47	8.53	3.20	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	85.90	51.26	30.48	8.31	2.77	5.54	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	68.39	39.89	39.89	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	67.19	81.00	27.61	11.05	8.28	3.68	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	72.61	24.20	6.05	3.03	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	37.25	24.83	0.00	31.04	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	49.70	20.09	16.92	1.06	2.11	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	430.03	102.08	27.74	20.56	6.69	5.63	3.18	1.06	0.00
Keratinocyte - epidermal, donor2	11349-117G8	206.14	46.27	17.57	7.03	7.03	1.17	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	222.16	110.27	27.26	15.14	11.45	6.34	1.14	1.23	0.00
Keratinocyte - oral, donor1	11251-116E9	405.71	92.29	45.18	41.77	18.28	11.81	4.65	1.59	0.00
Keratocytes, donor1	11527-119I6	524.00	149.57	53.29	53.29	21.32	13.75	2.06	2.06	0.00
Keratocytes, donor2	11607-120I5	178.11	87.89	14.06	30.47	11.72	2.34	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	162.23	206.29	29.44	26.28	13.04	6.32	2.37	1.58	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	112.09	0.00	15.39	15.39	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	221.14	61.49	15.10	38.83	8.63	2.16	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	299.06	120.06	46.36	62.05	13.72	9.11	4.38	3.46	0.35
Lens Epithelial Cells, donor3	11690-122I7	346.02	83.75	32.39	40.26	8.48	7.97	3.63	2.93	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	203.12	86.09	15.18	37.83	8.30	3.56	2.13	1.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	142.61	62.23	13.40	27.91	5.02	2.51	1.12	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	132.86	67.84	16.06	31.95	6.93	2.68	3.15	2.52	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	136.58	40.87	13.98	31.73	6.45	0.54	2.15	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	140.56	79.11	13.55	30.57	5.36	1.89	1.89	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	122.15	60.05	13.26	31.91	7.44	2.59	2.91	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	130.50	46.37	11.90	36.94	5.75	2.46	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	153.46	67.50	11.88	35.39	7.58	2.78	1.77	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	128.79	63.76	11.82	32.79	6.19	2.11	2.39	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	128.55	44.70	13.84	23.34	5.54	1.58	0.79	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	147.16	79.30	10.08	31.41	8.34	3.10	2.91	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	120.53	49.80	12.03	26.29	7.78	2.59	2.96	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	144.60	54.70	15.68	25.78	5.92	1.05	4.53	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	160.76	75.13	15.74	31.72	9.54	4.77	3.10	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	131.30	60.85	14.15	30.63	7.00	2.61	1.92	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	155.83	55.74	15.40	31.41	7.08	2.77	2.77	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	141.53	63.91	12.78	29.62	7.79	0.62	2.18	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	133.40	63.31	14.46	39.16	5.67	3.84	1.46	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	144.81	55.62	9.87	29.29	9.54	2.63	2.63	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	125.06	62.97	11.71	29.58	7.03	1.46	2.64	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	121.23	45.55	12.94	34.60	4.48	2.49	2.74	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	153.25	48.01	13.58	32.01	4.36	0.97	0.48	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	148.65	60.86	14.27	29.08	7.81	1.35	1.89	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	127.91	51.92	12.26	34.36	6.21	2.72	2.27	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	120.27	37.84	10.89	27.48	8.81	2.59	1.04	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	174.00	71.40	13.82	36.43	7.96	1.47	1.05	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	132.63	60.75	13.83	31.28	7.52	3.31	1.95	1.20	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	150.64	48.15	11.69	24.08	11.69	0.69	1.38	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	170.09	68.11	12.61	37.63	9.22	3.20	1.69	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	142.08	56.51	14.10	35.84	7.10	3.18	2.44	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	167.18	47.97	13.57	26.17	9.69	2.42	2.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	153.49	59.21	10.59	29.77	6.62	2.65	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	136.28	60.71	13.75	33.82	7.43	2.97	2.11	0.87	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	168.82	54.05	13.33	32.58	5.55	2.22	1.48	2.22	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	147.26	63.75	10.87	25.20	6.42	1.24	2.22	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	139.28	64.62	13.20	33.55	6.74	2.47	2.61	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	161.46	62.40	12.87	28.30	6.43	4.82	3.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	172.55	83.99	14.30	30.74	6.70	1.52	3.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	148.78	67.18	14.28	35.13	8.40	2.66	2.10	1.40	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	135.82	61.51	13.87	27.02	7.11	4.98	1.07	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	115.38	64.48	16.48	24.72	3.88	1.45	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	140.05	54.00	12.29	32.99	9.34	2.33	2.02	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	167.59	46.20	20.05	25.43	11.46	3.22	3.22	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	160.07	64.35	11.76	32.34	11.43	0.65	1.31	1.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	110.18	52.73	9.89	31.31	6.12	1.65	2.35	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	233.89	72.77	18.07	30.32	10.27	2.85	3.09	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	176.47	73.76	9.99	30.99	6.66	1.79	2.31	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	192.14	65.04	10.44	32.52	6.56	2.69	2.98	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	670.74	181.28	29.46	47.59	13.60	2.27	0.00	2.27	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1022.59	326.80	40.66	43.73	32.22	5.37	4.60	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	941.14	224.15	32.66	33.40	25.24	4.45	2.97	0.74	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	590.69	233.57	34.27	38.08	16.08	3.39	1.27	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	764.51	225.77	28.84	35.17	28.13	2.81	2.11	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	703.28	149.43	28.95	30.82	16.81	5.60	2.80	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	495.69	165.40	19.58	29.89	13.91	4.12	4.12	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	598.30	187.93	28.55	34.49	23.79	7.14	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	682.20	164.44	31.44	41.62	16.96	4.52	2.71	0.90	2.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	738.70	294.03	43.91	51.77	26.17	7.56	4.36	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1125.89	283.61	37.36	52.67	27.91	6.30	3.60	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	810.48	198.49	36.85	46.47	15.58	6.91	3.66	0.95	2.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	652.17	280.90	33.38	38.51	21.05	3.59	2.05	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1110.79	297.46	41.64	54.69	40.93	6.35	2.82	1.76	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1038.10	206.55	35.31	53.97	27.98	6.66	1.33	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	638.26	261.82	32.60	38.20	17.83	7.13	1.53	1.02	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1067.76	289.22	41.35	60.56	34.42	8.00	2.13	1.33	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	849.31	312.51	49.69	55.17	27.59	8.50	2.83	1.32	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	541.16	252.17	27.61	25.77	19.02	3.68	1.84	1.23	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	978.51	274.80	30.99	39.96	34.25	7.34	2.45	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	937.30	335.48	40.61	64.97	29.78	7.50	3.75	1.67	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	814.16	314.73	46.80	43.72	22.70	8.13	3.64	0.84	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1006.64	261.71	36.06	40.18	41.21	3.09	2.06	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	943.49	322.82	44.13	58.35	23.51	7.84	3.19	2.90	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	825.94	357.22	42.15	50.22	24.81	7.17	2.69	1.79	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1128.64	313.14	40.94	55.88	32.64	11.62	3.87	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	808.43	266.88	39.24	38.88	26.51	7.42	2.83	0.35	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	792.88	320.10	40.93	42.78	23.97	5.53	2.21	0.74	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	820.86	168.09	32.24	34.54	20.72	4.61	5.76	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	804.35	225.26	34.15	46.05	18.04	3.84	1.92	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	578.02	214.00	25.48	36.23	10.76	3.40	3.96	0.57	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1037.89	231.37	38.56	47.59	35.28	9.85	2.46	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	690.48	238.59	34.80	37.05	18.53	4.97	2.71	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	843.82	305.21	40.93	44.52	16.52	6.46	2.87	0.72	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1178.61	318.93	50.04	56.76	45.56	3.73	2.99	2.99	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	764.74	235.96	33.44	46.08	20.44	6.32	1.49	0.37	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	893.37	307.12	40.92	41.35	18.52	4.74	1.29	1.29	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1074.65	276.58	25.69	55.66	31.68	5.99	5.14	1.71	4.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	918.90	257.88	38.32	64.30	24.32	5.66	3.00	1.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	780.68	275.71	36.20	39.82	21.12	3.02	0.60	1.81	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1020.99	244.58	34.13	54.04	31.28	4.27	2.13	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	880.26	255.73	37.81	49.15	21.31	4.81	2.41	2.41	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	725.15	217.38	30.59	44.55	14.49	3.22	2.68	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	995.90	239.72	24.24	39.73	16.83	9.43	0.67	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	922.32	284.84	45.56	55.93	23.34	4.44	1.85	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	726.83	181.42	44.19	44.19	6.98	4.65	2.33	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	967.83	224.24	27.50	37.02	24.33	4.23	0.00	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	892.34	277.70	51.62	49.22	22.01	6.00	0.80	0.00	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	526.98	218.79	26.89	19.63	15.99	2.91	2.18	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	659.97	204.66	24.53	34.49	26.06	3.07	1.53	3.83	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	580.09	188.43	29.60	40.45	19.24	3.95	1.48	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	505.28	183.48	21.64	19.76	12.23	0.00	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	702.94	214.70	31.17	39.22	26.15	6.03	1.51	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	698.02	204.13	35.60	38.75	13.52	4.96	0.45	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	473.30	172.11	20.65	22.37	10.33	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	667.57	183.93	30.28	31.17	23.16	6.68	1.34	1.34	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	613.13	226.40	32.46	34.80	24.63	6.26	1.56	1.17	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	585.84	205.84	37.60	33.65	15.17	1.98	3.96	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	736.87	208.09	38.40	42.03	29.06	5.71	1.04	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	687.42	205.66	30.19	42.01	16.63	2.63	0.44	1.75	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	719.00	269.49	44.17	27.96	23.48	5.03	1.68	0.56	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	746.82	253.50	37.54	45.05	32.24	3.97	1.32	1.32	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	734.79	243.39	42.81	52.46	16.97	5.79	1.16	0.39	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	692.19	252.16	42.03	34.94	14.68	7.09	2.03	2.03	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	969.89	257.61	33.16	55.27	27.40	8.17	3.36	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	759.71	227.40	48.90	46.51	16.70	4.37	1.99	1.99	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	758.92	264.32	42.53	47.39	25.52	5.47	3.65	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	693.78	107.91	31.13	29.05	21.44	6.23	2.77	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	795.70	253.83	41.42	50.92	22.80	4.94	2.66	1.14	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	615.57	240.13	35.63	40.28	11.88	5.16	3.61	1.03	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	658.47	74.37	39.30	29.63	14.51	1.81	2.42	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	853.10	288.70	54.82	49.44	20.60	5.39	1.27	1.27	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	474.98	188.18	33.58	23.99	11.73	5.86	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	524.67	74.71	32.18	24.14	13.79	6.32	0.57	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	637.14	195.92	41.14	34.97	15.43	3.60	2.06	1.54	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	568.00	211.50	31.12	31.83	9.20	4.95	2.12	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	606.64	62.42	27.81	26.10	17.02	7.94	1.70	1.13	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	742.60	210.51	51.59	49.92	19.55	6.66	0.42	1.66	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	566.92	206.72	37.59	29.76	7.83	4.70	0.78	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	671.42	67.64	31.73	29.23	14.20	5.85	2.09	0.84	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	691.85	208.16	31.13	34.38	14.87	7.43	0.93	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	570.70	196.03	32.78	31.45	13.38	2.68	2.01	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	780.04	73.25	44.91	32.08	22.45	6.95	3.21	0.53	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	628.37	168.10	37.99	34.35	17.38	2.83	1.62	2.02	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	550.66	189.06	24.78	30.29	15.60	3.67	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	699.73	74.69	34.68	20.45	14.23	3.56	2.67	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	639.96	204.58	31.34	30.20	22.22	5.13	0.00	1.71	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	602.78	190.19	35.28	21.47	13.80	3.83	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	901.75	107.25	38.30	36.66	21.89	11.49	1.09	3.28	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	628.53	172.83	32.52	32.96	18.71	3.12	2.67	0.00	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	734.37	183.79	38.73	38.99	13.00	7.80	1.04	1.82	2.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	745.33	89.52	38.46	40.45	19.89	5.30	3.32	1.99	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	646.45	232.80	39.49	29.10	20.79	12.47	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	134.47	47.18	38.52	20.06	16.18	9.12	1.37	1.60	0.00
Macrophage - monocyte derived, donor2	11313-117C8	158.37	47.71	52.12	16.70	10.09	9.36	0.92	2.57	0.00
Macrophage - monocyte derived, donor3	11389-118C3	173.55	87.04	42.21	18.35	16.65	7.47	0.13	1.70	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	201.26	38.23	19.65	14.87	2.66	7.43	3.19	3.19	0.00
Mallassez-derived cells, donor2	11929-125I3	340.20	76.69	28.84	24.08	6.97	5.07	2.38	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	302.58	56.85	31.13	18.62	6.25	4.45	1.81	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	197.69	69.65	17.84	22.42	8.07	4.88	2.59	1.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	258.86	60.52	22.01	15.35	5.79	6.08	2.03	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	184.58	94.03	15.46	17.71	13.22	3.49	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	328.80	23.05	103.72	54.91	4.07	26.44	13.56	5.42	0.00
Mast cell, donor1	11563-120D6	190.65	73.54	40.23	42.93	23.79	10.60	2.27	2.92	0.00
Mast cell, donor2	11565-120D8	214.56	165.82	73.40	33.88	63.89	14.26	1.49	5.05	0.00
Mast cell, donor3	11566-120D9	177.62	173.35	98.15	39.40	57.41	12.16	2.93	4.05	0.00
Mast cell, donor4	11567-120E1	225.16	189.88	72.16	37.94	70.56	12.94	1.95	6.38	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	371.16	123.42	52.34	28.94	14.64	11.53	4.21	3.33	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	744.20	145.92	105.65	29.77	9.34	13.42	2.33	3.50	0.00
Mast cell, expanded, donor5	11939-126A4	158.55	89.02	34.30	39.92	22.49	11.24	3.10	5.74	0.00
Mast cell, expanded, donor8	11941-126A6	254.73	168.20	75.15	35.82	28.62	9.54	3.85	4.35	0.00
Melanocyte - dark, donor1	11502-119F8	282.87	107.16	32.83	65.97	12.54	8.95	3.98	2.49	0.00
Melanocyte - dark, donor2	11582-120F7	245.72	100.36	23.53	30.46	13.50	4.15	4.50	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	740.49	110.11	45.71	36.87	10.50	8.55	4.27	1.96	0.00
Melanocyte - light, donor1	11274-116H5	523.98	159.38	15.51	30.79	16.69	2.12	0.94	1.41	0.00
Melanocyte - light, donor2	11351-117H1	687.93	134.45	27.30	23.89	9.55	6.82	0.68	2.05	0.00
Melanocyte - light, donor3	11423-118G1	314.80	156.10	19.95	25.15	13.88	2.60	1.73	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	252.40	135.88	14.68	32.38	10.72	3.44	2.71	0.73	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	179.12	89.83	46.53	27.70	6.72	7.53	2.96	1.88	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	328.93	172.50	1.61	45.80	12.05	0.54	2.68	0.00	0.00
Meningeal Cells, donor1	11493-119E8	401.33	51.24	33.37	42.18	17.24	7.20	4.96	2.11	0.00
Meningeal Cells, donor2	11573-120E7	340.23	87.59	28.61	29.05	22.01	11.88	4.40	2.20	0.00
Meningeal Cells, donor3	11654-122E7	306.69	109.29	24.69	49.23	10.27	6.03	5.38	1.87	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	237.25	79.84	24.52	24.81	10.84	6.84	3.71	3.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	162.22	52.73	21.33	20.83	4.73	4.43	6.24	1.51	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	265.46	84.11	17.08	44.68	21.03	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	171.37	86.34	13.08	22.24	15.70	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	202.36	109.79	18.66	22.25	10.76	5.02	2.15	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	301.35	81.53	29.86	32.19	12.28	9.95	4.45	3.81	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	299.07	147.78	30.16	24.13	16.59	8.54	2.01	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	315.57	65.71	11.65	22.20	12.75	4.40	0.88	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	214.06	110.32	21.19	23.38	13.15	5.84	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	232.22	92.69	14.73	22.92	15.75	4.09	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	291.00	31.58	25.62	34.21	11.36	9.56	7.48	3.88	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	323.77	90.70	44.61	35.31	11.52	7.81	1.49	2.97	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	284.33	157.76	43.55	48.95	10.66	10.39	7.11	3.16	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	321.37	83.68	25.82	37.39	9.50	5.04	3.56	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	163.49	114.44	14.01	49.05	7.01	4.67	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	249.12	131.28	20.49	30.74	18.57	6.40	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	211.96	70.53	35.09	35.09	10.63	4.61	2.84	2.13	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	276.45	114.14	34.09	48.47	10.32	10.32	6.57	2.19	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	223.51	63.86	11.61	18.14	11.61	5.81	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	230.17	56.22	15.38	26.25	9.28	4.24	4.77	2.92	0.00
Mesothelial Cells, donor2	12156-128G5	240.22	41.54	15.01	48.04	7.01	2.50	4.00	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	474.56	107.10	67.13	28.54	14.38	16.77	2.46	2.82	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	263.31	83.72	133.68	28.36	10.80	17.55	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	196.53	91.86	63.54	22.90	24.87	12.07	0.99	1.72	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	215.25	100.70	63.90	23.56	17.96	9.42	0.88	1.47	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	121.00	117.54	93.34	31.11	10.37	6.91	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	136.69	61.06	46.80	20.46	17.05	8.06	0.31	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	183.99	71.36	48.54	20.12	13.07	6.64	0.62	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	104.22	118.12	71.80	18.53	11.58	11.58	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	190.70	85.59	64.82	24.28	25.03	10.26	0.25	1.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	209.93	91.70	71.22	23.74	16.29	5.59	1.86	2.79	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	214.13	116.80	136.26	19.47	38.93	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	188.58	81.69	53.24	21.95	19.71	8.13	0.81	2.44	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	194.81	88.70	64.94	22.17	10.30	6.73	0.40	3.17	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	188.13	179.58	145.38	34.21	17.10	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	176.99	46.02	44.25	10.62	7.96	5.31	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	175.15	70.67	60.41	24.70	12.16	10.64	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	111.85	92.11	78.95	27.63	11.84	9.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	137.10	55.82	43.29	13.58	14.43	8.49	0.42	1.91	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	131.68	63.54	45.12	19.34	6.45	8.29	0.92	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	161.84	65.57	44.41	21.76	19.37	6.26	0.30	2.09	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	107.31	75.45	82.16	30.18	23.47	10.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	169.75	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	133.23	66.49	45.16	17.06	15.31	10.29	0.75	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	156.39	64.17	46.35	20.44	10.70	10.93	0.24	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	126.06	80.72	68.56	30.41	7.74	8.85	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	156.80	60.78	43.52	14.28	14.74	6.68	0.69	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	147.66	73.83	47.54	19.35	15.35	7.78	0.42	1.89	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	157.76	92.74	42.40	13.66	14.68	6.11	0.41	1.02	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	171.42	63.93	33.47	13.52	15.66	6.01	1.07	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	172.50	69.13	47.13	21.34	15.34	4.89	0.00	2.45	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	51.59	51.59	0.00	10.32	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	135.57	54.54	33.07	11.83	10.51	5.91	0.44	1.10	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	154.62	68.44	47.15	19.26	14.70	6.59	1.01	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	97.76	67.94	81.19	23.20	9.94	6.63	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	176.94	75.56	36.15	18.21	15.22	5.98	0.00	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	139.69	64.11	47.64	18.23	14.70	5.88	0.59	1.76	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	78.50	55.61	49.06	17.45	16.35	3.27	1.09	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	157.14	57.19	37.00	12.01	10.57	4.32	1.44	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	147.28	68.84	52.83	16.81	13.21	8.00	1.20	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	182.37	113.81	52.11	21.94	19.20	5.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	204.24	63.07	33.54	15.02	13.02	7.01	0.50	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00	26.95	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	114.16	106.00	42.81	8.15	16.31	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	162.91	52.11	31.53	13.14	8.76	3.50	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	206.38	70.63	60.70	16.55	17.66	5.52	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	180.59	116.55	42.91	22.41	23.69	3.84	0.00	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	182.22	51.82	30.49	15.12	11.16	5.70	0.50	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	187.89	53.58	46.63	18.09	20.88	4.18	0.00	4.18	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	247.51	99.44	35.36	15.47	19.89	6.63	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	203.07	52.31	28.38	18.46	10.26	5.47	0.68	1.71	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	232.37	65.20	51.20	21.01	14.44	5.25	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	151.27	76.35	39.77	17.04	13.49	4.62	0.00	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	158.51	40.40	20.48	12.91	9.82	4.21	0.56	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	207.40	73.15	47.80	15.38	11.64	9.56	0.00	2.49	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	201.63	97.32	29.72	18.07	17.48	4.66	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	192.16	56.41	20.81	13.27	15.08	3.62	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	202.02	75.13	49.67	15.44	15.86	8.77	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	303.19	86.63	57.75	21.66	43.31	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	127.45	46.18	12.93	6.46	15.70	1.85	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	225.37	60.90	45.53	22.76	17.64	9.11	0.57	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	164.16	62.04	27.50	14.51	13.54	4.15	0.14	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	163.52	45.87	16.84	11.92	7.00	4.41	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	249.66	64.35	64.35	21.02	16.73	7.29	0.43	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	166.42	99.73	24.14	11.43	14.61	3.81	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	159.07	54.45	21.88	10.41	8.01	1.33	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	245.75	71.24	39.81	13.47	19.46	9.58	0.30	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	122.61	41.67	19.21	13.28	9.75	2.97	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	150.34	40.13	15.61	8.28	7.33	4.46	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	243.69	63.02	51.97	19.24	17.03	8.18	0.44	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	188.08	75.46	21.24	12.89	15.17	4.93	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	144.61	35.51	14.77	8.24	7.39	2.27	0.57	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	232.53	69.07	43.75	17.45	9.09	6.88	1.47	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	179.86	86.67	11.73	16.94	11.73	2.61	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	135.84	37.64	14.11	13.53	10.29	2.65	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	282.27	64.01	48.73	18.45	14.99	4.61	0.86	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	124.47	36.27	23.90	14.01	4.53	8.24	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	114.94	34.54	11.91	8.93	7.74	4.17	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	41.44	33.90	18.83	22.60	7.53	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	85.55	65.94	60.60	7.13	19.60	7.13	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	193.20	109.41	49.94	12.16	30.56	9.53	0.66	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	162.00	97.83	86.26	10.52	32.61	5.26	0.00	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	107.15	66.82	53.18	12.26	13.44	8.70	0.40	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	196.51	142.49	80.09	14.90	29.80	13.97	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	146.46	88.25	49.19	9.01	15.77	7.89	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	202.15	108.93	69.52	12.78	24.77	10.92	0.27	2.40	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	77.13	33.70	29.52	11.76	8.37	5.77	0.45	1.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	117.88	89.88	59.67	14.00	22.10	6.63	2.21	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	170.75	101.50	49.47	14.29	29.31	10.63	1.10	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	144.67	96.45	56.00	9.33	32.67	6.22	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	87.11	40.08	55.05	15.50	10.15	9.62	0.53	2.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	200.92	112.05	50.23	15.46	27.05	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	199.97	135.33	63.63	6.06	43.43	10.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	166.97	106.67	72.52	15.60	34.15	13.49	0.00	2.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	157.99	55.84	159.35	13.62	17.71	5.45	0.00	5.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	225.07	68.03	134.15	30.52	10.17	17.17	2.54	3.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	233.23	49.40	109.33	29.96	8.10	19.44	1.62	6.48	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	182.76	155.57	111.77	16.61	28.70	15.10	0.00	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	228.41	125.62	970.73	11.42	22.84	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	264.26	120.71	786.25	13.05	13.05	26.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	275.64	66.53	242.38	23.76	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	150.59	263.53	627.45	12.55	62.75	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	371.20	80.57	27.14	24.13	11.20	6.25	4.74	2.80	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	248.76	183.44	30.31	28.22	20.38	6.27	5.75	2.61	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	453.22	441.21	13.35	23.36	51.40	2.67	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	355.18	680.31	24.21	10.85	63.44	5.01	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	192.42	289.21	27.19	8.94	29.85	6.08	3.23	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	646.32	430.88	98.94	82.98	60.64	9.58	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	436.52	565.03	14.28	15.64	46.92	7.48	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	312.40	264.62	49.62	38.59	18.38	7.35	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	490.52	495.13	20.09	20.09	56.92	5.86	2.09	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	227.56	345.17	20.22	9.76	35.56	4.65	0.93	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	478.30	537.48	25.13	17.56	68.37	6.49	1.35	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	368.97	259.43	38.47	36.58	31.54	7.99	2.31	1.89	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	701.49	356.31	33.40	167.02	44.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	347.45	279.94	24.32	15.88	39.21	7.45	0.50	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	204.09	192.72	36.00	12.72	15.70	8.66	2.17	2.17	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	266.80	318.71	15.87	11.33	39.22	4.31	2.49	1.36	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	558.49	565.19	26.45	30.05	44.58	8.00	0.98	1.96	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	343.73	205.77	43.56	41.37	24.06	8.57	3.10	2.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	475.27	416.39	29.17	23.87	40.84	7.96	2.12	2.65	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	412.41	420.81	26.41	20.41	33.62	5.40	1.80	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	218.89	233.33	54.48	15.42	13.78	7.55	6.89	2.30	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	328.66	415.99	22.60	11.55	39.52	6.99	1.46	1.63	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	479.41	244.11	58.38	49.92	37.39	11.46	3.35	3.17	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	489.45	513.36	30.94	16.88	42.90	9.14	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	289.16	416.96	28.96	9.65	18.85	5.98	3.22	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	503.87	474.30	29.24	26.67	43.38	5.46	2.25	2.89	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	206.93	238.66	55.18	17.93	8.97	11.38	9.31	2.76	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	697.85	505.69	151.71	116.31	20.23	20.23	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	378.06	228.58	51.69	36.76	25.62	8.69	2.01	2.90	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	328.55	448.37	27.94	11.85	30.48	5.08	1.27	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	193.44	266.78	21.12	6.65	14.24	4.51	1.19	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	439.98	536.56	28.76	15.45	52.80	5.58	1.29	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	415.28	207.64	54.17	81.25	9.03	9.03	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	319.89	406.20	29.32	21.99	44.65	7.33	1.00	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	266.91	257.44	37.87	23.90	24.35	8.12	0.90	2.71	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	277.36	390.45	18.25	7.94	17.46	5.95	1.98	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	289.74	435.53	13.00	13.00	29.72	4.64	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	212.27	306.86	34.43	9.46	15.89	6.05	2.27	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	427.56	492.41	24.77	14.34	40.41	6.19	2.61	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	451.47	625.35	24.40	24.40	67.98	9.15	2.61	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	471.28	262.78	47.49	27.14	27.59	11.31	1.81	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	333.36	431.25	21.17	12.35	33.51	3.53	0.00	0.00	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	408.22	397.58	19.95	13.96	30.58	5.98	1.33	2.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	407.25	386.91	29.76	15.87	45.14	9.92	2.48	1.98	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	419.19	543.23	21.06	13.78	52.06	5.74	0.38	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	244.07	386.83	24.20	17.24	12.70	5.44	0.60	2.12	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	374.41	186.77	34.70	29.84	19.23	6.63	1.33	1.33	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	495.37	493.33	23.72	16.26	26.43	4.74	2.71	0.68	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	485.41	306.57	61.31	66.42	5.11	0.00	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	457.87	492.01	35.36	10.97	32.92	8.54	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	338.97	498.86	26.44	11.96	35.88	7.24	1.26	1.57	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	316.88	736.66	26.03	14.22	46.31	8.47	1.21	1.82	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	479.43	495.25	21.36	5.54	31.65	3.96	4.75	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	334.42	344.63	49.88	23.81	7.94	2.27	10.20	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	399.57	237.72	20.23	55.64	5.06	5.06	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	259.64	61.37	29.07	30.44	6.71	4.35	2.98	1.74	0.00
Myoblast, donor2	11322-117D8	250.67	124.47	25.70	28.58	12.27	6.71	2.69	2.49	0.00
Myoblast, donor3	11398-118D3	406.28	94.34	41.03	33.97	14.29	7.74	3.20	3.03	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	240.35	390.08	178.77	33.56	49.18	17.07	1.61	3.79	0.00
Natural Killer Cells, donor1	11230-116C6	117.16	97.48	130.39	21.53	16.61	14.76	1.85	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	120.62	206.57	129.67	13.87	26.84	9.65	0.90	1.81	0.00
Natural Killer Cells, donor3	11387-118C1	107.12	163.44	128.65	17.85	23.01	12.52	2.21	0.92	0.00
Neural stem cells, donor1	11275-116H6	465.29	220.30	68.23	69.68	9.80	15.24	15.61	3.63	1.09
Neural stem cells, donor2	11352-117H2	652.79	296.55	53.92	84.73	32.74	11.55	11.55	0.00	0.00
Neurons, donor1	11494-119E9	425.57	242.37	28.45	50.07	20.48	4.55	12.52	3.41	0.00
Neurons, donor2	11574-120E8	398.06	275.20	26.42	65.39	26.86	6.38	8.59	2.86	0.44
Neurons, donor3	11655-122E8	197.32	415.19	33.71	30.42	25.49	12.33	9.87	4.93	0.00
Neutrophils, donor1	11233-116C9	53.82	119.71	38.05	15.78	30.62	4.64	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	66.67	168.13	63.78	11.60	31.89	11.60	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	72.69	197.30	54.98	14.05	60.47	6.11	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	200.54	126.33	36.10	62.69	17.34	11.64	8.07	5.22	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	138.71	156.94	20.51	35.17	12.70	7.49	3.91	3.91	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	157.43	47.53	24.07	22.06	15.84	7.62	4.01	3.21	0.00
Olfactory epithelial cells, donor1	11933-125I7	146.46	173.03	23.81	19.82	17.07	5.64	3.58	1.65	0.00
Olfactory epithelial cells, donor2	11934-125I8	239.41	163.42	26.49	21.86	12.45	7.24	3.47	1.59	0.00
Olfactory epithelial cells, donor3	11935-125I9	246.42	172.98	32.46	26.33	18.39	7.83	4.09	2.27	0.00
Olfactory epithelial cells, donor4	11936-126A1	216.61	214.18	28.83	31.17	22.99	7.69	3.41	2.43	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	658.99	147.45	40.32	29.49	13.24	7.82	4.81	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	509.40	162.07	31.90	31.48	15.95	4.89	6.38	3.62	0.00
Osteoblast - differentiated, donor2	11353-117H3	450.39	206.90	34.29	29.72	16.00	6.86	2.29	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	208.56	151.45	34.76	20.48	15.52	4.34	3.10	1.24	0.00
Osteoblast, donor1	11277-116H8	578.88	142.86	42.61	52.18	14.27	7.82	2.93	2.74	1.95
Osteoblast, donor2	11354-117H4	554.83	120.10	34.41	46.35	10.53	7.73	3.51	4.21	4.21
Osteoblast, donor3	11426-118G4	387.63	219.32	36.79	34.48	22.75	9.24	2.31	1.07	0.53
Pancreatic stromal cells, donor1	11249-116E7	225.33	100.66	22.83	41.11	11.46	6.65	3.45	1.52	0.00
Pericytes, donor1	11491-119E6	377.19	61.98	39.50	41.39	18.80	10.46	3.45	4.12	0.11
Pericytes, donor2	11571-120E5	347.25	115.22	36.90	34.86	20.83	6.79	4.98	3.40	0.68
Pericytes, donor3	11652-122E5	302.94	148.52	18.72	36.21	19.53	6.31	2.24	2.24	0.00
Perineurial Cells, donor1	11499-119F5	390.26	126.47	36.17	47.36	16.61	9.04	6.78	2.15	0.00
Perineurial Cells, donor2	11579-120F4	275.85	97.90	28.71	41.13	14.81	9.11	2.76	1.38	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	128.13	110.28	116.02	18.49	17.85	15.30	1.59	1.91	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	91.09	170.42	83.99	10.77	16.16	11.02	0.98	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	114.66	194.64	88.91	14.49	26.53	8.41	0.65	1.68	0.00
Placental Epithelial Cells, donor1	11278-116H9	305.89	105.47	126.76	28.22	11.24	8.61	1.67	2.63	0.00
Placental Epithelial Cells, donor2	11355-117H5	683.07	134.18	36.59	43.25	7.76	13.31	6.65	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	535.38	223.22	47.71	66.16	24.74	10.41	7.85	1.96	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	456.32	188.29	30.70	22.47	16.77	7.28	2.85	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	247.24	90.60	40.89	27.58	7.32	9.00	7.50	2.06	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	162.12	89.41	18.14	22.58	7.44	6.92	4.05	1.70	0.00
Preadipocyte - breast, donor2	11328-117E5	381.63	204.44	39.40	31.30	20.94	7.66	4.28	2.93	0.00
Preadipocyte - omental, donor1	11468-119C1	360.06	130.96	51.25	45.93	8.74	11.61	12.15	2.77	0.00
Preadipocyte - omental, donor2	11329-117E6	341.76	130.94	46.70	32.30	10.48	8.29	8.29	3.49	0.00
Preadipocyte - omental, donor3	11403-118D8	438.20	192.96	35.10	32.23	20.48	7.16	5.59	2.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	379.93	95.47	40.35	24.61	20.67	17.72	9.84	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	271.49	68.18	14.13	20.88	8.91	3.38	2.15	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	188.94	104.65	18.24	31.17	12.04	4.78	1.77	1.95	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	241.97	176.93	30.14	47.85	20.95	6.81	2.72	0.85	0.17
Preadipocyte - visceral, donor1	11280-116I2	173.63	69.21	17.23	44.90	9.97	3.91	2.70	1.77	0.00
Preadipocyte - visceral, donor2	11357-117H7	112.28	120.11	15.65	40.04	6.44	1.84	2.30	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	169.90	64.05	16.72	24.87	15.88	5.02	1.25	1.04	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	606.88	290.24	0.00	46.92	17.35	0.00	6.79	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	369.00	110.09	24.24	20.85	6.91	4.20	2.71	0.68	0.00
Prostate Epithelial Cells, donor3	11404-118D9	133.50	127.25	22.78	5.63	13.90	4.47	1.04	0.31	0.00
Prostate Stromal Cells, donor1	11254-116F3	236.34	81.67	18.45	35.08	6.83	4.90	4.90	1.94	0.00
Prostate Stromal Cells, donor2	11332-117E9	215.16	120.31	22.77	25.10	7.53	5.92	1.97	1.26	0.00
Prostate Stromal Cells, donor3	11405-118E1	214.60	134.20	16.06	35.87	12.83	5.94	4.17	2.61	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	536.89	118.98	33.58	38.32	17.15	7.66	1.46	1.46	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	411.64	138.48	29.94	39.58	11.30	7.49	1.87	1.52	0.00
Renal Epithelial Cells, donor1	11517-119H5	471.72	102.97	12.68	27.90	14.20	3.04	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	374.87	167.87	19.21	34.85	14.94	4.27	2.13	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	399.32	148.32	41.29	45.73	11.33	10.80	3.28	1.91	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	377.19	130.72	36.77	19.06	30.64	7.49	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	250.39	97.17	25.20	14.69	16.04	4.99	0.67	1.48	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	334.13	154.74	24.20	27.75	9.55	7.77	2.22	1.11	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	317.42	161.70	17.30	33.94	19.96	3.99	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	500.26	113.57	25.53	36.53	19.15	9.46	2.42	3.08	0.00
Renal Mesangial Cells, donor2	11598-120H5	496.57	234.49	45.77	40.75	29.47	7.52	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	453.57	196.68	26.35	45.50	23.03	6.66	0.83	1.94	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	349.22	73.82	25.23	22.28	15.57	4.56	1.34	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	257.65	131.99	18.98	16.02	17.29	5.06	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	389.94	199.60	24.11	37.03	22.18	6.94	0.96	2.31	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	306.73	92.05	29.30	49.26	10.89	5.70	2.85	1.30	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	365.82	96.36	36.67	36.10	11.09	9.95	1.71	3.41	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	276.83	113.20	25.73	30.87	13.38	5.15	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	147.28	77.53	26.35	22.58	1.51	4.77	5.02	2.26	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	262.86	115.19	64.81	26.59	19.24	8.95	2.14	2.27	1.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	333.24	214.42	50.03	19.65	26.80	8.04	2.68	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	246.02	156.86	26.97	13.21	8.81	5.50	9.36	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	387.48	267.41	76.57	23.78	20.30	11.60	4.06	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	340.67	61.89	56.69	24.83	15.47	10.14	2.21	2.08	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	355.81	232.28	40.32	34.46	25.52	7.05	2.09	2.38	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	430.65	175.45	51.08	39.26	16.28	9.93	3.79	2.34	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	430.43	89.56	64.63	44.41	20.59	14.14	2.85	3.72	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	374.34	244.98	45.80	40.79	25.06	9.21	2.56	2.45	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	432.22	252.40	47.15	37.67	22.88	12.48	3.00	2.08	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	438.93	102.54	42.17	25.05	28.07	11.23	1.78	3.15	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	385.44	227.36	39.18	32.98	24.81	10.29	2.57	2.12	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	468.76	182.59	46.59	34.23	18.28	10.57	1.61	3.23	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	433.09	105.44	49.92	24.67	25.68	9.47	3.44	3.01	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	385.58	216.35	48.94	37.35	24.57	8.37	2.68	2.04	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	379.26	241.85	45.80	36.07	28.99	6.86	1.11	1.99	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	474.88	94.63	47.41	21.79	28.10	7.07	1.72	0.96	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	386.53	257.32	42.20	35.96	27.95	7.45	1.96	1.58	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	428.43	166.11	51.67	39.27	12.59	8.27	2.82	3.95	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	478.81	123.82	56.00	21.90	26.01	10.48	1.33	2.79	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	425.96	245.69	48.57	37.28	32.41	8.08	1.56	2.14	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	417.82	252.45	39.53	36.86	27.69	5.73	3.44	2.67	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	402.08	96.01	52.65	22.75	24.56	8.97	2.78	1.71	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	424.10	222.00	49.89	36.72	17.10	8.97	1.96	1.40	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	391.36	208.50	38.62	31.96	24.95	6.49	2.73	1.88	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	443.06	128.73	48.32	21.33	25.71	9.48	2.19	1.64	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	385.31	247.35	43.66	32.87	23.18	6.99	2.82	2.70	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	465.28	260.18	45.00	37.21	28.21	9.67	2.55	2.96	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	492.50	73.12	60.15	21.94	25.71	9.91	1.89	1.65	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	353.77	256.95	41.47	31.75	26.59	9.33	2.18	2.58	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	445.71	241.33	46.07	30.17	24.09	9.82	2.81	2.57	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	463.23	96.01	46.03	24.47	29.86	8.92	1.04	2.70	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	331.37	249.52	48.67	30.31	17.70	5.75	2.21	1.77	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	395.42	272.18	39.90	27.99	27.99	8.15	2.51	1.67	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	474.14	111.17	60.16	28.80	28.13	8.88	3.10	1.48	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	427.78	285.75	45.30	36.61	36.44	8.51	2.38	1.70	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	450.37	284.95	45.69	33.16	28.53	7.90	3.47	3.08	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	505.15	91.99	47.63	26.65	23.73	11.52	2.41	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	407.12	295.32	44.03	36.62	32.51	7.68	2.06	2.19	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	378.08	267.60	38.91	34.64	24.63	6.24	2.79	2.46	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	475.33	109.76	40.39	24.03	26.42	8.01	1.70	2.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	409.25	263.07	47.64	40.24	31.66	11.98	2.37	2.96	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	483.52	284.68	40.52	33.32	31.19	9.86	1.07	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	493.47	123.89	56.69	21.29	22.26	12.31	2.77	2.90	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	477.63	285.01	60.72	44.05	25.00	11.43	3.10	3.81	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	744.49	454.48	63.49	46.15	36.28	12.09	2.82	3.63	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	538.11	118.66	73.17	24.49	26.93	13.56	2.54	3.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	465.00	330.50	50.66	38.78	30.74	8.38	4.19	4.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	431.56	288.31	35.66	32.64	28.41	6.65	2.12	3.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	502.40	150.29	60.70	30.47	30.47	11.99	3.43	3.43	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	368.98	190.82	56.62	28.96	17.61	10.77	2.04	3.78	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	469.71	329.77	52.32	40.76	29.81	10.34	1.22	3.65	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	544.63	138.94	59.07	29.24	26.82	8.14	3.92	3.01	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	389.72	358.73	52.70	35.06	29.40	11.76	2.94	2.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	524.50	429.84	74.29	36.84	32.65	14.08	3.29	2.40	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	311.72	77.93	58.09	21.14	23.02	9.33	4.13	3.07	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	351.76	373.74	45.68	26.25	37.78	10.03	3.20	1.49	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	442.32	499.41	60.10	27.64	40.87	12.62	4.21	2.40	0.00
Schwann Cells, donor1	11498-119F4	325.36	125.26	19.56	24.26	29.72	7.33	1.32	2.07	0.00
Schwann Cells, donor2	11578-120F3	156.51	51.04	6.80	27.22	3.40	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	270.57	132.11	15.77	31.11	16.21	4.38	2.63	1.31	0.00
Sebocyte, donor1	11220-116B5	608.02	101.34	33.41	30.68	14.79	10.96	1.64	2.74	0.00
Sebocyte, donor2	11301-117B5	340.07	163.60	23.44	18.38	12.87	5.51	0.00	1.84	0.00
Sebocyte, donor3	11378-118B1	332.25	151.08	30.92	28.65	21.44	8.66	1.65	2.27	0.00
Sertoli Cells, donor1	11255-116F4	291.56	119.28	33.13	59.64	28.16	8.28	4.97	8.28	0.00
Sertoli Cells, donor2	11333-117F1	285.26	386.94	28.24	56.49	22.59	5.65	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	166.10	112.00	33.43	41.88	17.07	9.50	4.22	2.64	0.09
Skeletal Muscle Cells, donor2	11358-117H8	299.98	211.79	13.73	26.75	18.07	2.89	1.45	1.45	1.45
Skeletal Muscle Cells, donor3	11430-118G8	286.76	139.62	39.29	34.28	38.46	5.02	2.51	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	170.29	68.34	20.89	16.81	12.25	5.81	1.57	1.10	0.00
Skeletal Muscle Cells, donor5	11455-119A6	228.91	89.04	23.49	20.22	15.90	5.95	1.78	1.34	0.30
Skeletal Muscle Cells, donor6	11459-119B1	205.61	80.80	17.54	15.39	14.16	4.16	1.85	1.39	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	274.57	127.52	29.49	53.80	17.51	9.45	3.40	2.77	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	277.39	186.49	26.68	35.67	16.27	8.70	2.00	2.28	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	268.56	142.96	24.90	30.36	18.16	8.83	1.79	1.29	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	480.74	134.04	59.90	49.20	12.05	11.63	8.34	2.95	4.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	363.33	200.48	43.43	45.60	18.09	8.69	0.00	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	426.83	170.90	75.95	22.98	19.54	12.80	3.03	2.34	1.24
Skin - palm, donor1	10286-104F7	139.68	217.57	80.58	32.23	2.69	21.49	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	281.68	94.71	29.12	7.50	11.96	6.49	1.15	1.01	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	142.31	38.44	31.90	1.64	4.91	8.18	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	294.84	100.23	31.42	8.70	12.98	7.27	1.17	1.04	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	266.76	89.10	34.33	11.68	5.56	5.70	2.64	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	341.23	181.45	34.74	14.35	21.52	5.63	0.70	1.41	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	134.69	40.60	33.83	7.40	4.02	9.52	0.63	1.90	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	283.54	209.04	37.92	13.79	25.78	7.12	1.05	0.67	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	703.57	71.59	43.51	32.71	18.52	9.57	6.79	2.78	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	155.19	25.12	15.56	12.45	4.00	5.11	4.22	2.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	256.29	100.52	24.69	38.21	18.81	3.53	2.94	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	203.09	118.01	46.41	33.15	7.29	3.31	2.21	1.33	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	304.39	64.97	17.72	21.66	11.42	5.51	2.36	1.97	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	286.62	95.03	23.95	40.17	18.54	10.04	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	184.14	133.10	39.03	60.05	9.01	8.01	8.01	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	503.57	119.77	30.87	43.25	15.97	7.19	4.66	2.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	147.40	89.55	21.94	32.36	12.63	4.65	5.10	2.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	169.64	58.77	34.06	8.71	6.66	8.32	3.97	2.05	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	236.38	83.35	17.58	38.75	11.07	3.26	3.58	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	165.97	74.72	15.36	26.58	11.52	7.09	3.54	3.54	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	236.89	116.74	14.09	25.06	15.94	4.13	1.71	1.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	294.60	65.23	17.57	31.56	8.46	5.04	0.98	2.28	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	207.01	139.43	15.83	38.36	9.44	6.70	2.74	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	275.04	125.78	29.30	51.02	18.18	8.84	3.54	2.27	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	361.12	226.47	177.50	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	350.47	123.98	23.84	22.89	17.64	3.34	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	234.04	71.23	21.97	36.28	8.11	3.98	2.65	1.92	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	256.35	114.51	17.22	26.26	11.19	6.46	2.15	1.08	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	228.18	129.10	16.90	24.35	13.96	5.67	2.20	0.94	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	351.12	84.61	23.05	26.14	14.69	4.02	1.70	1.39	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	372.95	108.87	29.10	23.71	7.55	4.31	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	213.38	69.33	15.24	18.53	14.94	3.29	2.69	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	369.39	86.37	22.87	36.19	11.61	5.12	0.68	2.05	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	286.00	125.18	32.43	58.43	11.23	8.72	6.60	3.61	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	321.55	138.08	32.61	32.71	10.77	6.64	6.24	2.52	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	267.37	113.78	17.98	38.91	12.06	5.92	5.01	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	285.00	73.06	18.72	13.28	14.49	4.23	1.81	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	194.72	56.96	16.16	23.05	5.83	4.50	1.85	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	264.59	46.21	27.30	22.90	15.18	6.92	3.86	1.46	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	325.20	170.42	23.04	34.06	15.78	6.14	3.63	2.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	178.58	84.47	17.00	32.72	10.15	6.85	5.83	2.03	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	325.07	95.14	31.66	39.35	13.27	7.69	3.47	1.81	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	195.79	171.79	25.51	29.26	26.26	9.00	2.25	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	259.74	544.02	244.23	25.84	11.63	6.46	2.58	6.46	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	455.30	126.50	49.30	47.90	22.32	6.98	1.86	3.26	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	304.44	160.05	23.22	34.33	7.57	1.51	3.03	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	381.71	111.25	21.31	24.44	16.61	7.21	2.51	1.88	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	263.14	57.82	18.29	25.07	7.08	5.90	0.88	1.18	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	206.27	49.32	20.49	32.32	8.41	5.91	2.75	2.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	277.49	151.36	23.83	59.80	16.35	7.01	6.07	4.20	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	307.12	101.32	24.75	34.68	12.95	5.32	2.88	1.44	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	265.66	159.60	22.95	33.14	15.81	5.10	1.02	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	234.10	126.92	18.99	21.81	26.14	4.14	3.01	1.32	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	212.13	69.73	12.58	31.58	8.80	3.49	3.49	1.96	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	376.96	96.02	18.52	52.28	12.32	8.30	4.94	2.09	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	169.04	98.57	10.95	30.95	10.95	1.90	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	284.30	97.86	16.39	29.36	13.21	4.65	5.14	1.47	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	365.89	84.18	53.25	35.13	22.76	9.06	5.52	3.98	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	68.46	43.30	8.78	12.29	6.44	1.17	0.88	2.34	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	145.96	129.06	18.27	23.13	13.80	7.00	2.92	2.92	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	200.46	101.55	15.07	17.19	11.90	2.64	1.59	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	100.05	85.55	13.02	17.48	6.32	3.35	7.07	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	278.85	98.82	20.12	19.40	7.19	2.52	3.95	2.87	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	185.10	63.59	17.03	12.49	7.67	1.99	0.85	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	147.70	72.08	26.00	11.42	8.67	4.73	1.18	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	109.20	76.95	10.92	13.97	6.09	4.06	5.08	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	166.52	178.10	17.17	34.74	26.75	3.59	3.99	2.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	182.25	145.47	26.75	20.06	15.05	7.52	2.93	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	209.01	142.55	29.34	28.88	16.50	6.42	3.21	1.83	0.00
Synoviocyte, donor1	11291-117A4	243.39	119.17	30.63	36.53	11.45	4.88	7.24	1.51	0.00
Synoviocyte, donor2	11368-117I9	133.60	150.69	27.49	38.89	17.27	6.87	5.03	2.35	0.00
Synoviocyte, donor3	11440-118H9	100.53	82.66	20.33	14.30	22.12	6.93	2.90	1.56	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	474.54	136.14	35.73	39.66	16.44	9.65	0.71	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	210.10	134.78	15.86	27.75	13.87	5.95	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	296.15	107.21	22.69	41.68	16.90	5.79	0.69	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	261.79	72.62	25.02	15.77	10.18	6.16	1.29	0.86	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	206.04	92.78	20.10	7.73	10.05	4.25	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	218.18	77.88	35.51	8.02	12.03	2.86	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	274.71	113.06	66.31	28.17	21.04	8.98	1.60	3.44	1.35
Urethra, donor2	10319-105A4	131.29	345.30	39.57	17.98	23.38	1.80	8.99	3.60	0.00
Urothelial Cells, donor1	11520-119H8	471.55	72.79	28.16	17.27	11.42	5.05	0.53	1.06	0.00
Urothelial Cells, donor2	11600-120H7	296.42	116.56	43.26	18.03	11.62	6.01	2.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	341.74	171.45	39.88	19.25	15.82	6.42	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	383.38	131.73	39.68	28.08	19.39	10.03	3.12	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	435.10	120.12	730.51	46.27	75.63	63.17	0.89	11.57	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	506.08	131.52	916.38	42.89	81.49	91.50	4.29	15.73	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	314.88	401.13	390.18	40.39	58.87	32.17	0.00	3.42	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	137.05	107.78	207.64	30.65	24.79	18.94	2.07	5.51	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	121.43	121.43	238.22	24.40	30.21	19.17	1.74	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	402.96	96.84	554.98	35.40	65.60	55.19	3.12	9.37	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	395.57	81.68	818.67	41.30	49.56	67.92	4.59	6.42	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	274.78	389.81	365.16	55.69	62.08	22.82	0.91	6.39	0.00
Wilms' tumor cell line:G-401	10809-111A8	245.61	189.85	93.26	19.74	18.63	16.41	2.71	2.34	0.00
Wilms' tumor cell line:HFWT	10597-108E3	53.68	150.49	1.76	20.24	27.28	0.00	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	257.25	233.23	95.81	22.07	26.81	15.64	1.12	1.68	0.00
achilles tendon, donor2	10292-104G4	144.66	204.59	53.73	4.13	24.80	4.13	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	202.69	168.53	163.94	13.77	13.77	23.20	1.27	5.86	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	222.42	116.32	146.04	30.65	16.48	21.59	2.55	6.04	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	424.97	306.98	186.02	31.10	26.95	21.37	8.90	4.87	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	325.45	132.52	160.28	19.32	9.25	28.84	3.54	6.80	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	105.69	97.82	80.95	25.30	6.75	14.90	5.62	1.69	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	172.57	98.76	79.31	32.15	12.69	11.42	2.54	5.71	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	138.83	74.86	41.65	21.50	19.87	2.99	1.36	3.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	421.25	139.68	175.37	43.62	19.39	20.27	4.41	4.85	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	223.78	169.47	166.61	36.75	17.97	12.25	4.49	3.27	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	199.20	205.80	198.81	18.25	30.29	23.30	1.94	5.05	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	121.07	92.00	203.32	19.69	11.59	23.74	0.55	5.70	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	218.43	85.81	148.22	19.50	7.80	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	205.43	96.90	112.01	28.82	15.80	20.22	7.90	4.88	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	164.40	118.32	72.23	30.03	14.24	13.98	0.52	5.70	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	182.94	154.30	77.74	34.48	18.41	13.15	1.17	3.51	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	342.99	218.44	95.74	25.56	24.17	18.59	1.39	4.18	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	95.00	170.67	114.74	30.02	17.68	11.10	0.82	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	224.99	269.50	48.81	5.22	34.69	3.68	0.61	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	149.35	86.62	105.82	31.15	9.81	7.25	0.85	3.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	163.17	73.40	103.42	29.42	14.86	12.13	0.61	4.55	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	179.08	80.15	111.21	26.48	11.79	11.55	0.96	2.17	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	58.36	47.00	71.05	6.68	7.80	12.92	0.45	3.12	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.69	24.35	0.00	8.01	5.34	0.00	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	195.11	156.09	241.57	57.60	37.16	33.45	9.29	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	206.03	91.53	88.89	33.90	13.18	16.95	3.39	3.77	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	224.17	91.59	32.71	52.34	19.63	7.41	4.36	3.49	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	200.57	106.84	93.72	50.61	46.86	5.62	0.00	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	88.08	161.08	105.74	11.30	29.91	19.78	0.24	1.88	0.00
adipose tissue, adult, pool1	10010-101C1	169.70	123.16	41.11	27.61	14.27	4.65	1.09	1.55	0.00
adipose, donor1	10184-103D4	107.90	282.65	289.69	17.01	9.38	26.39	5.28	9.38	0.00
adipose, donor2	10185-103D5	338.20	720.61	62.45	19.87	42.17	11.76	2.84	4.06	0.41
adipose, donor3	10186-103D6	500.19	594.13	80.60	22.60	29.95	11.16	5.45	1.63	3.27
adipose, donor4	10187-103D7	874.55	702.94	403.04	13.87	19.07	14.73	5.20	2.60	19.94
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	433.06	178.81	240.99	25.25	27.15	49.24	2.68	8.84	0.16
adrenal gland, adult, pool1	10081-102A9	705.71	331.03	130.96	29.10	18.19	29.10	0.00	10.91	47.29
adult T-cell leukemia cell line:ATN-1	10421-106C7	22.95	69.90	107.26	10.14	15.88	14.94	0.13	1.60	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	114.69	218.67	47.52	47.52	36.44	8.58	2.14	2.50	0.36
amniotic membrane cells, donor1	12235-129G3	214.00	132.15	57.27	11.36	19.94	9.97	1.39	2.78	0.00
amniotic membrane cells, donor2	12236-129G4	391.19	171.76	68.30	23.67	22.31	10.48	7.44	3.72	0.00
amniotic membrane cells, donor3	12237-129G5	154.08	109.59	28.28	12.37	22.68	4.71	1.77	1.77	0.00
amygdala - adult, donor10196	10167-103B5	368.78	245.46	39.13	35.57	33.20	8.30	14.23	1.19	0.00
amygdala, adult, donor10252	10151-102I7	382.01	613.57	53.13	50.29	27.17	11.56	8.92	2.64	3.04
amygdala, newborn, donor10223	10360-105E9	290.81	218.51	70.69	15.82	14.85	6.78	5.81	5.16	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	205.77	206.66	32.34	70.29	29.92	2.42	5.48	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	592.92	227.15	202.09	14.70	9.35	26.72	7.35	25.39	668.07
aorta, adult, pool1	10052-101G7	274.19	344.21	46.48	34.32	36.09	7.26	1.57	1.96	3.33
appendix, adult	10189-103D9	249.95	250.34	90.43	32.21	32.21	12.03	1.16	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	776.26	394.15	505.58	78.76	19.95	46.78	2.75	5.50	0.00
artery, adult	10190-103E1	500.00	296.19	73.37	70.65	35.33	6.79	2.72	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	132.26	95.90	130.82	32.88	12.60	18.83	6.08	1.45	6.37
b cell line:RPMI1788	10427-106D4	247.14	108.85	62.90	24.24	15.46	9.81	4.31	2.38	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	250.26	147.60	32.74	25.80	14.70	8.32	5.27	1.94	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	279.04	103.70	54.28	27.39	14.39	10.82	1.79	2.08	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	33.81	16.57	0.00	3.51	4.85	0.00	1.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.59	79.41	34.11	6.71	18.45	3.91	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	154.27	142.21	44.54	35.85	18.25	6.08	2.61	2.28	0.00
blood, adult, pool1	10053-101G8	318.91	562.52	232.54	26.58	106.30	19.93	0.00	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	108.76	59.94	45.39	26.55	18.84	6.85	2.57	0.86	0.00
bone marrow, adult	10192-103E3	332.01	197.72	45.21	34.42	8.77	4.72	6.75	0.67	0.00
brain, adult, donor1	10084-102B3	315.72	376.20	30.75	62.53	51.25	10.25	2.05	1.03	2.05
brain, adult, pool1	10012-101C3	299.78	237.97	30.62	99.33	23.83	5.57	7.35	3.45	0.33
brain, fetal, pool1	10085-102B4	374.00	502.22	10.69	56.10	85.48	16.03	13.36	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	1234.57	934.93	146.68	104.40	55.50	17.18	10.24	2.97	7.60
breast carcinoma cell line:MDA-MB-453	10419-106C5	472.83	222.31	507.78	17.85	12.98	66.41	2.00	11.98	0.00
breast, adult, donor1	10080-102A8	292.95	556.86	62.50	17.05	84.60	8.21	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	334.36	195.13	57.04	10.93	35.57	9.15	1.65	3.43	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	130.49	154.92	30.61	25.36	24.43	3.40	1.55	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	150.33	93.93	48.35	39.37	8.98	4.14	4.14	1.61	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	592.87	481.51	0.00	26.63	67.54	0.00	10.65	0.00	27.11
carcinoid cell line:NCI-H1770	10703-109H1	105.32	205.46	87.45	18.34	24.45	7.05	1.41	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	361.94	193.93	33.36	28.00	14.77	5.14	1.97	0.98	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	190.14	199.96	147.36	12.68	25.35	21.55	3.17	1.27	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	553.65	347.10	103.28	64.15	19.16	19.43	19.43	7.45	0.27
caudate nucleus - adult, donor10196	10177-103C6	249.84	123.19	40.30	10.36	29.93	3.45	2.30	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	275.59	184.90	46.01	20.08	11.38	9.54	3.51	2.18	0.33
caudate nucleus, adult, donor10258	10379-105H1	184.92	55.78	39.74	13.75	7.64	5.35	3.82	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	251.24	137.34	50.17	14.65	3.66	5.49	4.76	1.46	1.46
cerebellum - adult, donor10196	10173-103C2	276.76	480.69	84.48	58.27	87.40	11.65	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	225.04	618.97	49.32	77.08	36.72	3.63	3.63	3.20	0.21
cerebellum, adult, pool1	10083-102B2	139.36	285.96	35.87	48.64	38.63	4.83	4.48	3.45	0.00
cerebellum, newborn, donor10223	10357-105E6	295.58	255.73	53.14	24.91	7.47	4.98	11.62	0.00	0.00
cerebral meninges, adult	10188-103D8	283.91	409.22	48.16	87.24	31.52	6.05	5.80	2.77	1.01
cerebrospinal fluid, donor2	10294-104G6	266.77	378.60	55.55	20.46	18.27	10.23	2.92	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	177.43	141.91	239.97	15.38	5.90	37.38	7.33	3.02	0.00
cervical cancer cell line:ME-180	10553-107I4	227.36	131.08	104.73	22.54	9.61	14.58	3.31	3.81	0.00
cervix, adult, pool1	10013-101C4	239.80	162.10	54.17	53.13	21.84	11.76	4.41	4.20	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	375.24	182.53	21.32	57.96	25.50	3.90	3.07	1.67	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	95.36	163.28	62.70	40.49	53.56	11.76	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	336.29	119.18	74.69	16.16	11.31	9.82	3.48	2.24	0.00
choriocarcinoma cell line:SCH	10785-110H2	907.71	114.09	84.77	12.32	9.86	16.14	2.09	2.59	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	425.26	108.39	43.64	7.12	14.47	8.06	1.42	4.98	0.00
chorionic membrane cells, donor1	12238-129G6	191.47	85.48	137.33	11.40	16.24	15.96	0.85	5.70	0.57
chorionic membrane cells, donor2	12239-129G7	504.32	170.82	95.26	42.16	24.86	22.07	3.58	3.08	0.00
chorionic membrane cells, donor3	12240-129G8	239.58	57.70	181.33	8.79	18.13	20.88	2.20	2.75	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	275.68	164.60	134.30	14.14	4.04	19.19	15.15	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	220.91	189.22	79.34	27.09	31.12	11.91	1.54	2.50	2.88
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	190.91	158.39	50.05	25.98	27.45	9.08	1.27	3.17	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	133.02	75.24	41.09	15.41	6.93	4.62	1.54	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	136.90	100.38	43.54	15.00	10.64	5.81	0.73	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	154.34	94.07	37.06	15.68	10.79	5.29	0.61	1.02	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	81.27	88.04	81.56	11.48	7.07	11.78	0.29	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	53.43	34.66	0.26	13.29	4.95	0.00	1.04	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	193.15	120.01	28.80	37.26	29.94	4.57	2.74	1.83	0.00
clear cell carcinoma cell line:TEN	10636-108I6	186.35	170.90	30.19	31.93	21.69	5.21	9.89	1.21	0.17
colon carcinoma cell line:CACO-2	10513-107D9	530.27	228.80	0.00	44.48	21.78	0.00	3.11	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	208.28	177.88	63.09	55.11	20.52	12.92	4.18	3.80	0.00
colon, adult, donor1	10082-102B1	191.60	257.05	44.03	17.85	35.70	8.33	1.19	5.95	0.00
colon, adult, pool1	10014-101C5	284.83	187.18	43.48	22.80	26.67	7.05	0.82	2.23	0.00
colon, fetal, donor1	10070-101I7	302.20	439.39	85.90	27.81	57.47	10.51	3.09	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	513.35	339.18	114.59	77.92	41.25	9.17	4.58	18.33	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	75.11	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	221.39	77.76	140.65	12.32	6.37	15.30	11.05	2.97	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	306.24	90.11	108.97	16.45	5.89	11.77	6.94	3.17	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	237.74	68.67	130.58	21.15	6.06	13.54	8.60	2.26	0.00
corpus callosum, adult, pool1	10042-101F6	237.60	130.80	31.84	53.29	16.58	5.75	5.42	1.00	1.44
cruciate ligament, donor2	10295-104G7	133.73	239.09	55.92	10.54	16.21	5.67	0.81	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	849.11	403.69	138.84	24.88	22.47	21.67	2.41	5.62	106.74
diencephalon, adult	10193-103E4	340.78	160.55	28.56	36.48	14.64	4.08	1.68	0.72	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	137.77	106.31	123.99	17.68	12.63	22.50	3.90	5.97	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	178.48	111.81	0.00	30.26	14.10	0.00	8.21	0.00	3.59
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	192.10	94.84	85.70	31.53	12.28	18.29	3.37	3.61	0.00
ductus deferens, adult	10196-103E7	206.31	106.64	36.38	35.38	15.95	6.48	4.98	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	381.66	364.38	135.38	12.96	33.13	20.16	2.88	7.20	27.36
duodenum, fetal, donor1, tech_rep2	10071-101I8	534.08	178.76	126.53	41.20	19.13	16.92	2.94	4.41	39.73
dura mater, adult, donor1	10041-101F5	185.33	109.68	43.61	41.38	12.97	9.17	3.88	3.39	5.53
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	269.82	131.02	209.64	15.99	4.89	29.09	0.89	2.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	300.34	135.27	140.14	22.07	4.01	26.65	2.44	6.30	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	134.42	186.83	35.76	61.66	30.83	1.85	3.70	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	75.98	111.70	19.37	31.78	20.89	1.51	1.51	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	108.99	159.62	37.05	48.16	24.70	4.32	1.23	1.54	1.54
embryonic pancreas cell line:2C6	10603-108E9	137.91	164.18	21.02	48.60	15.76	3.94	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	253.74	133.07	102.57	20.11	8.38	12.07	4.69	2.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.21	75.03	75.76	31.35	23.20	10.69	1.99	5.62	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	191.05	72.53	78.48	9.01	10.29	10.45	1.93	2.09	0.00
epidermoid carcinoma cell line:A431	10426-106D3	133.83	86.04	15.45	13.34	12.01	2.45	2.11	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	716.12	290.25	118.12	62.69	30.91	23.98	3.96	3.74	0.00
epididymis, adult	10197-103E8	314.59	165.15	39.56	41.65	15.91	5.23	3.14	2.51	4.60
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	116.56	47.55	31.93	33.71	17.56	11.18	3.55	2.13	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	152.58	43.65	35.00	18.09	7.86	5.90	0.39	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	260.53	187.14	124.50	16.77	9.57	19.79	4.98	3.67	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	270.16	196.84	120.96	21.06	11.32	18.90	5.81	2.85	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	292.96	216.89	111.36	22.41	11.88	19.72	3.36	4.15	0.00
esophagus, adult, pool1	10015-101C6	254.40	160.54	74.32	25.91	18.16	12.95	0.96	2.87	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	89.67	67.50	1.63	23.17	10.02	0.75	3.76	2.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	540.86	408.06	99.00	41.05	12.07	7.24	0.00	0.00	16.90
eye - muscle lateral, donor2	10298-104H1	488.18	534.47	107.31	14.73	8.42	4.21	2.10	4.21	6.31
eye - muscle medial, donor2	10299-104H2	586.36	492.60	78.88	17.86	20.84	4.46	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	530.83	386.37	88.28	41.27	22.93	13.76	3.44	1.15	13.76
eye - vitreous humor, donor1	10268-104D7	504.26	246.30	107.85	51.01	14.57	13.12	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	416.44	235.93	90.51	47.03	25.17	12.71	7.12	3.56	17.03
fibrosarcoma cell line:HT-1080	10758-110E2	147.20	103.86	27.31	18.34	19.87	6.67	2.05	1.41	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	221.51	169.99	34.66	30.86	31.81	2.61	1.19	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	303.05	214.11	30.02	122.44	24.30	6.29	7.51	2.91	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	895.04	236.00	26.12	27.32	9.61	3.30	3.00	0.60	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	301.83	151.42	0.00	50.38	16.73	0.00	2.93	0.00	0.00
gall bladder, adult	10198-103E9	207.39	145.34	50.94	31.14	15.69	7.00	3.14	3.38	0.00
gamma delta positive T cells, donor1	11937-126A2	90.19	141.19	82.14	20.94	28.99	10.74	1.07	3.22	0.00
gamma delta positive T cells, donor2	11938-126A3	94.87	99.72	93.00	23.90	26.14	12.70	0.75	1.87	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	347.66	206.57	42.45	12.25	5.91	7.82	2.53	1.27	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	284.51	181.62	54.74	21.86	21.86	5.61	3.67	1.35	0.97
gastric cancer cell line:AZ521	10549-107H9	407.10	119.69	165.27	47.71	12.13	27.71	4.92	5.25	3.77
gastric cancer cell line:GSS	10560-108A2	213.25	179.38	0.00	58.57	32.95	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	86.36	63.05	22.16	13.71	3.43	4.11	0.69	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	17.56	25.47	0.00	7.46	3.10	0.00	1.26	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	342.76	110.15	24.35	30.37	17.21	7.14	3.08	3.22	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	210.01	181.58	44.40	18.46	16.96	2.99	3.99	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	102.81	96.79	4.64	40.53	12.14	1.58	4.43	0.53	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	99.29	111.37	6.04	33.14	14.47	1.40	3.09	1.12	0.14
glioblastoma cell line:T98G	10485-107A8	199.55	153.42	50.33	58.06	15.78	9.71	4.41	3.42	0.00
glioma cell line:GI-1	10413-106B8	195.64	137.95	0.00	66.48	19.04	0.00	8.79	0.00	16.99
globus pallidus - adult, donor10196	10175-103C4	314.89	157.44	53.94	17.49	18.95	5.10	4.37	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	354.43	345.39	43.45	32.46	20.26	7.32	6.59	2.44	0.24
globus pallidus, adult, donor10258	10367-105F7	275.21	316.29	27.38	13.69	8.22	0.00	4.11	0.00	5.48
globus pallidus, newborn, donor10223	10364-105F4	280.85	141.22	44.77	15.45	6.40	3.73	9.59	2.66	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	802.66	589.76	127.25	78.31	29.37	31.81	0.00	9.79	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	76.50	54.64	65.57	21.86	43.71	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	99.31	67.95	67.95	26.13	0.00	5.23	10.45	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	165.44	145.92	23.36	32.32	22.72	8.96	4.48	1.60	0.00
hIPS +CCl2, biol_rep1	14383-156B9	197.42	102.38	191.91	4.13	6.89	24.33	0.92	3.67	13.31
hIPS +CCl2, biol_rep2	14384-156C1	184.73	67.22	170.10	9.15	5.49	21.03	2.29	6.40	14.63
hIPS +CCl2, biol_rep3	14385-156C2	249.26	66.34	211.91	6.44	12.88	28.98	1.93	7.09	14.17
hIPS, biol_rep1	14380-156B6	273.08	51.74	188.28	2.87	2.87	28.75	1.44	1.44	2.87
hIPS, biol_rep2	14381-156B7	213.30	78.87	196.84	3.43	4.80	24.69	2.06	4.80	7.54
hIPS, biol_rep3	14382-156B8	897.12	100.42	123.59	29.79	13.24	23.17	6.62	1.10	24.28
hairy cell leukemia cell line:Mo	10712-109I1	155.17	89.36	85.63	15.23	12.64	13.51	2.59	2.59	0.00
heart - mitral valve, adult	10205-103F7	291.19	252.93	40.66	57.10	14.65	3.59	2.09	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	300.17	327.63	38.44	74.52	20.66	3.40	2.88	1.83	0.00
heart - tricuspid valve, adult	10207-103F9	402.17	344.71	63.28	71.61	34.14	3.33	0.00	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	352.81	336.08	73.05	45.50	26.73	12.04	1.63	1.63	1.43
heart, adult, diseased, donor1	10051-101G6	302.34	482.47	47.27	69.41	19.16	3.83	2.13	1.70	0.43
heart, adult, pool1	10016-101C7	575.86	362.90	55.65	89.23	30.13	5.29	1.15	2.30	0.00
heart, fetal, pool1	10046-101G1	645.75	316.05	82.14	101.96	25.88	7.39	6.57	1.75	6.57
hepatic mesenchymal tumor cell line:LI90	10778-110G4	289.40	253.30	25.92	25.92	31.47	5.24	3.70	2.47	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	258.05	416.21	211.67	24.97	13.08	21.41	1.19	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	283.75	295.13	115.47	40.55	18.34	16.46	2.54	2.32	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	294.09	290.21	113.12	38.35	17.84	18.93	3.40	3.52	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	319.13	304.47	125.10	49.92	16.57	17.79	2.53	3.03	0.00
hepatoma cell line:Li-7	10484-107A7	124.90	179.61	56.94	22.35	10.57	5.00	1.00	0.56	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	181.50	106.73	61.31	13.37	14.27	12.56	1.81	2.11	0.00
hippocampus - adult, donor10196	10169-103B7	316.07	244.15	48.26	26.50	32.18	12.30	15.14	2.84	0.95
hippocampus, adult, donor10252	10153-102I9	343.70	518.21	41.02	54.29	28.57	7.55	8.57	2.25	2.45
hippocampus, adult, donor10258	10374-105G5	423.26	139.92	41.33	26.39	24.40	3.98	7.97	1.49	0.50
hippocampus, newborn, donor10223	10363-105F3	220.30	237.57	31.02	31.02	18.33	7.75	4.93	2.11	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	158.08	107.42	131.83	6.71	3.66	19.53	4.27	7.32	40.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	219.92	185.16	105.44	22.38	8.64	11.58	2.55	1.18	17.87
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	186.11	127.71	95.21	21.84	6.35	6.60	2.03	2.79	30.21
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	445.45	685.10	140.40	47.36	26.50	13.53	3.95	1.69	11.28
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	436.38	891.09	129.88	54.22	48.03	11.36	3.61	2.07	11.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	396.31	491.21	138.94	44.41	22.40	14.43	5.31	2.66	12.53
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	352.68	319.98	49.92	30.36	16.93	7.30	4.09	3.50	6.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	545.03	499.15	51.92	36.84	29.94	9.48	7.54	3.23	8.19
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	621.44	351.59	47.55	33.37	15.01	6.26	5.00	4.17	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	419.36	175.94	44.28	32.44	14.44	6.87	7.34	1.42	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	554.96	431.20	42.27	36.32	30.54	7.71	6.43	2.09	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	479.39	190.54	43.09	29.63	10.77	6.06	7.41	4.04	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	180.27	151.63	189.50	18.47	7.82	24.41	2.19	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	167.04	133.14	216.66	11.30	11.30	24.07	3.93	3.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	96.00	74.18	212.95	6.11	1.75	22.69	5.24	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	473.65	929.35	193.39	53.65	44.86	22.91	5.15	4.01	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	484.04	770.10	187.95	40.99	54.51	22.68	3.92	3.92	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	235.39	558.23	172.42	18.99	14.99	18.99	4.50	3.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	263.56	438.95	68.39	28.64	34.85	7.54	3.96	3.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	357.41	431.53	80.03	24.10	52.29	10.00	5.91	3.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	263.74	378.70	64.84	15.35	19.73	11.59	4.07	3.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	511.79	430.95	75.61	29.88	24.01	11.76	3.92	2.12	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	523.14	352.15	81.29	20.61	26.13	11.32	4.06	3.77	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	547.63	417.00	78.32	25.41	20.03	9.86	1.49	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	285.98	226.31	129.14	18.47	12.38	16.44	2.03	3.88	29.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	305.25	221.95	137.51	14.26	18.83	14.55	1.43	3.71	30.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	201.30	130.25	162.92	7.76	4.90	21.23	2.45	0.41	47.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	548.19	458.06	117.24	40.49	39.79	16.20	6.34	4.58	8.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	719.63	612.89	126.06	38.01	43.71	19.32	3.17	2.53	13.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	603.12	493.27	114.39	33.89	22.70	15.74	4.24	3.33	6.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	509.37	345.44	54.81	24.30	27.92	8.27	4.65	4.14	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	466.24	395.18	49.15	21.92	30.55	3.32	3.32	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	322.46	224.21	46.43	18.98	10.26	6.67	3.59	1.03	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	529.19	257.69	73.88	28.63	16.87	8.69	7.67	1.79	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	569.43	358.17	77.24	24.99	19.69	10.60	6.06	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	606.58	303.12	57.47	24.87	17.14	6.39	4.37	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	271.21	218.80	135.00	14.97	15.46	18.35	4.11	1.69	41.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	220.60	135.48	123.89	12.48	8.47	15.15	5.35	2.23	45.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	231.71	193.66	124.39	10.73	10.73	11.22	1.46	2.44	48.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	527.80	606.65	116.44	47.98	34.23	9.78	3.36	3.67	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	201.70	257.01	257.01	32.53	6.51	19.52	22.77	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	221.40	307.45	160.51	33.09	10.59	17.87	8.94	3.97	13.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	411.02	340.97	45.43	31.74	26.82	6.57	5.47	2.74	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	360.07	259.11	43.79	22.80	16.28	5.43	4.34	1.09	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	302.49	218.86	26.69	18.15	14.59	6.05	6.05	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	449.91	311.47	39.38	21.48	10.74	7.16	10.74	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	518.68	217.49	49.84	31.55	15.84	11.24	7.72	2.84	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	540.95	320.85	35.02	21.28	15.36	7.54	3.23	2.16	0.27
immature langerhans cells, donor1	11904-125F5	255.95	123.01	107.27	18.89	17.92	12.11	1.21	1.21	0.00
immature langerhans cells, donor2	11905-125F6	181.40	129.12	123.57	11.09	20.60	15.84	0.79	1.58	0.00
insula, adult, pool1	10039-101F3	333.11	224.00	35.11	113.65	25.74	8.14	8.61	4.35	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	257.84	317.99	51.05	11.71	35.44	13.01	1.63	7.15	0.00
kidney, adult, pool1	10017-101C8	276.65	137.37	44.26	35.85	12.62	8.51	3.10	2.30	2.70
kidney, fetal, pool1	10045-101F9	516.30	173.80	96.77	59.63	14.50	14.50	6.93	4.53	35.16
large cell lung carcinoma cell line:IA-LM	10509-107D5	297.82	149.55	33.94	31.24	16.05	3.83	11.08	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	283.12	153.59	481.08	27.10	6.91	48.94	3.18	4.29	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	197.81	164.05	76.15	22.75	18.72	7.52	3.49	1.10	0.00
left atrium, adult, donor1	10079-102A7	269.16	591.16	43.59	19.61	37.59	3.27	1.63	0.00	1.09
left ventricle, adult, donor1	10078-102A6	311.99	667.46	28.82	43.99	39.95	2.02	2.02	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	444.34	214.24	645.17	5.20	9.03	126.68	1.37	59.65	0.27
leiomyoma cell line:10964C	10569-108B2	248.24	117.83	30.54	34.13	7.18	7.90	5.39	3.23	0.00
leiomyoma cell line:15242A	10570-108B3	222.28	76.63	25.00	21.74	4.35	0.54	4.89	1.63	0.00
leiomyoma cell line:15425	10571-108B4	230.43	109.27	22.82	27.92	9.23	4.61	2.43	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	114.29	139.69	6.35	0.00	6.35	0.00	6.35	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	156.83	442.27	19.87	29.28	18.82	2.09	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	282.87	243.55	0.00	31.88	28.81	0.00	1.65	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	239.78	203.70	18.43	34.37	23.59	4.06	4.06	1.56	0.16
liposarcoma cell line:SW 872	10726-110A6	229.91	230.52	0.12	48.61	23.88	0.00	3.17	0.00	0.12
liver, adult, pool1	10018-101C9	177.94	138.08	27.55	27.06	13.94	6.48	1.30	2.11	0.00
liver, fetal, pool1	10086-102B5	549.38	334.89	54.56	40.45	24.46	12.23	0.94	3.76	0.94
locus coeruleus - adult, donor10196	10182-103D2	1153.91	324.02	97.41	72.47	17.64	16.92	6.71	3.50	22.60
locus coeruleus, adult, donor10252	10165-103B3	1043.45	358.58	72.16	38.57	19.19	17.16	5.91	3.32	40.97
locus coeruleus, adult, donor10258	10375-105G6	1170.87	438.16	77.31	35.83	29.34	15.24	2.82	3.39	77.31
locus coeruleus, newborn, donor10223	10362-105F2	352.06	243.12	51.32	30.28	13.46	7.57	10.09	1.68	26.08
lung adenocarcinoma cell line:A549	10499-107C4	77.64	49.82	0.00	23.80	12.59	0.00	2.08	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	167.53	97.21	65.49	33.78	21.37	11.72	0.69	2.76	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	291.45	188.37	45.74	25.44	16.74	2.90	2.64	0.53	0.00
lung, adult, pool1	10019-101D1	238.74	147.30	51.86	28.23	25.40	6.50	1.30	2.36	0.71
lung, fetal, donor1	10068-101I5	590.79	71.35	148.13	34.25	20.83	16.27	7.14	2.28	2.57
lung, right lower lobe, adult, donor1	10075-102A3	318.46	407.35	39.41	21.54	46.28	6.87	0.46	1.37	0.00
lymph node, adult, donor1	10077-102A5	144.85	253.25	48.76	15.15	54.44	6.63	0.47	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	374.14	371.94	75.40	15.78	35.07	15.12	0.66	2.41	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	76.52	85.42	213.86	25.05	12.53	25.05	5.43	5.74	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	151.21	54.37	30.58	16.99	6.80	4.25	2.55	0.00	0.00
mature adipocyte, donor1	12231-129F8	349.42	246.41	49.28	26.64	20.87	9.77	2.66	4.00	0.00
mature adipocyte, donor2	12232-129F9	267.50	195.70	42.75	22.62	18.05	6.85	1.04	1.66	0.00
mature adipocyte, donor3	12233-129G1	244.65	177.56	30.82	20.15	11.38	5.45	1.42	3.56	0.00
mature adipocyte, donor4	12234-129G2	254.79	160.83	42.11	21.58	13.95	10.00	1.58	2.90	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	263.75	141.05	82.44	30.97	26.45	8.10	8.58	3.57	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	331.64	342.92	47.38	76.71	37.23	6.77	18.05	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	346.48	659.12	42.11	87.36	30.53	7.36	11.77	1.47	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	248.11	316.42	37.17	40.66	39.39	5.40	11.75	2.22	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	107.05	145.86	34.55	23.88	8.96	2.99	16.63	1.28	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	260.72	376.15	37.80	96.86	24.98	6.75	16.03	2.53	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	300.51	688.88	39.05	80.43	23.34	5.31	9.76	1.70	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	362.14	165.66	26.97	19.26	13.48	3.85	3.85	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	215.30	430.61	28.71	200.95	71.77	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	184.49	270.63	38.76	34.10	18.66	3.59	6.46	2.15	0.72
medulla oblongata - adult, donor10196	10174-103C3	371.86	194.69	51.92	25.31	24.66	7.14	9.09	2.60	8.44
medulla oblongata, adult, donor10252	10155-103A2	590.11	384.53	50.31	52.01	15.79	11.77	6.50	4.02	7.59
medulla oblongata, adult, pool1	10038-101F2	811.46	144.89	67.42	69.87	13.71	13.31	4.73	3.59	18.20
medulla oblongata, newborn, donor10223	10361-105F1	424.60	192.34	46.18	40.27	11.11	5.21	4.51	1.74	8.68
medulloblastoma cell line:D283 Med	10838-111E1	677.30	304.88	191.74	52.25	10.18	19.71	19.48	2.66	0.22
medulloblastoma cell line:ONS-76	10759-110E3	136.95	167.27	7.70	17.73	20.66	1.35	2.08	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	383.08	179.11	0.00	35.65	27.60	0.00	6.90	0.00	0.00
melanoma cell line:G-361	10465-106H6	126.77	75.20	0.00	14.66	10.04	0.00	2.99	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	62.77	101.31	19.36	11.22	14.11	3.08	0.90	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	522.53	403.57	94.28	70.49	22.91	10.57	4.41	7.93	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	443.01	267.52	102.65	47.70	14.26	14.00	2.85	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	204.07	53.40	25.47	37.59	12.43	5.68	3.53	1.23	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	182.69	58.35	27.99	44.54	12.72	7.09	4.73	2.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	124.64	31.89	37.27	20.29	5.80	4.56	3.73	2.07	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	135.70	38.77	21.07	43.97	9.69	4.50	3.65	1.69	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	100.91	45.45	17.52	40.25	10.40	4.04	5.78	3.27	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	86.76	62.47	15.96	34.70	8.33	5.55	6.25	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	131.30	46.00	14.76	23.69	8.07	3.78	5.49	1.20	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	116.74	46.70	19.90	31.28	9.32	5.29	4.37	1.84	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	195.11	48.81	26.26	27.72	11.01	6.90	3.85	1.46	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	171.91	42.54	24.04	29.17	9.05	5.40	3.65	1.22	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	193.19	45.67	22.34	32.01	11.24	3.84	3.27	1.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	92.55	48.42	8.89	19.43	8.56	2.96	2.63	1.65	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	174.07	45.66	21.31	36.25	8.86	3.60	1.80	1.11	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	131.95	73.31	23.04	34.91	9.08	2.44	3.49	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	181.71	37.16	18.37	32.26	10.21	6.12	6.12	1.63	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	148.10	80.16	15.10	24.08	9.35	1.80	3.24	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	231.83	49.45	16.14	40.76	14.17	3.62	3.41	1.55	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	194.02	52.67	14.36	22.12	4.56	4.10	3.19	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	209.36	25.59	32.73	29.79	5.45	8.81	6.71	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	134.05	42.74	18.83	30.34	9.12	3.59	3.44	2.99	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	196.07	52.87	18.64	36.24	10.50	3.68	2.71	1.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	118.55	106.77	20.62	27.61	19.14	7.73	2.58	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	155.67	75.55	12.59	32.05	9.44	2.00	2.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	302.29	223.14	53.47	31.16	19.79	10.10	2.11	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	263.04	144.76	29.68	31.97	26.03	6.85	3.65	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	230.46	118.17	26.86	30.95	17.65	7.16	2.56	2.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	274.84	142.66	36.65	29.32	19.89	10.21	2.88	2.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	279.13	137.41	34.20	32.66	14.79	7.70	6.16	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	211.35	119.80	31.30	28.24	14.12	7.77	3.29	1.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	246.06	131.32	41.29	34.86	16.92	9.14	3.38	2.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	273.51	139.90	34.97	36.15	14.93	10.22	3.93	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	256.72	124.19	37.53	29.66	14.83	8.34	2.78	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	144.91	48.30	193.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	301.11	155.17	42.69	37.78	18.46	8.36	2.88	2.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	262.59	124.94	33.91	33.91	17.40	10.49	3.35	2.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	284.58	137.24	36.05	32.69	17.31	8.65	3.85	1.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	280.86	149.60	48.40	29.33	19.80	16.13	3.67	3.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	237.65	130.23	32.56	32.89	17.45	6.04	4.03	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	254.63	128.14	38.48	27.02	15.15	8.19	6.14	2.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	232.39	125.43	34.36	37.37	10.31	5.58	3.87	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	232.42	180.47	35.55	32.81	8.20	0.00	8.20	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	247.92	165.28	51.65	15.49	5.16	0.00	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	221.50	155.90	35.73	23.71	16.24	5.85	2.60	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	267.72	138.22	49.47	37.83	33.46	5.82	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	272.94	256.94	43.18	21.86	27.19	12.79	2.67	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	236.34	172.55	40.07	16.36	30.26	9.00	6.54	4.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	267.44	211.46	41.20	24.49	32.26	6.61	2.33	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	239.25	201.48	29.38	8.39	12.59	4.20	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	230.48	157.96	33.78	37.75	12.92	7.95	1.99	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	147.78	143.02	33.37	28.60	19.07	9.53	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	249.05	183.23	41.51	27.28	21.35	13.64	1.19	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	252.22	160.84	31.68	21.93	31.68	9.75	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	297.58	54.10	0.00	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	272.99	210.28	37.37	34.84	36.10	11.40	1.90	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	231.43	181.07	49.67	27.25	24.49	9.66	5.17	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	229.96	182.68	38.69	32.24	17.19	4.30	6.45	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	267.45	119.75	19.96	47.90	7.98	15.97	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	199.75	137.76	51.66	27.55	13.78	17.22	13.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	182.55	127.13	47.67	29.34	15.08	16.71	7.33	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	203.38	138.23	42.90	24.63	16.68	15.09	11.12	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	104.94	89.02	31.24	25.35	10.02	8.25	2.36	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	91.95	102.24	34.29	18.70	14.96	9.97	4.36	2.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	105.60	109.61	49.46	17.38	13.37	8.02	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	219.98	98.16	36.66	13.01	18.92	11.83	1.18	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	202.87	130.97	43.66	25.68	15.41	10.27	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	244.38	107.39	40.62	24.09	8.95	12.39	2.75	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	799.61	176.15	80.16	22.76	12.37	15.34	3.46	2.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	669.54	172.71	58.32	21.31	8.97	19.07	1.12	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	653.87	191.46	75.06	22.26	12.72	12.09	3.18	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1063.07	246.63	98.73	32.64	20.15	14.10	0.81	2.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1203.68	259.49	100.31	26.17	17.44	21.81	4.36	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1057.99	285.09	72.22	20.27	25.34	17.74	5.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	625.70	233.65	47.34	25.49	10.32	13.96	1.82	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	826.97	370.56	76.82	9.04	22.59	18.08	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	731.43	306.41	49.42	18.94	9.06	17.30	2.47	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	220.85	110.32	35.92	12.10	9.92	6.94	2.98	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	325.79	172.63	35.37	18.17	17.85	5.52	1.62	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	329.02	174.19	33.61	14.26	18.34	17.32	4.07	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	210.45	58.03	44.88	35.59	11.61	10.83	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	294.36	140.09	40.40	53.63	32.84	8.98	0.71	4.72	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	292.14	82.71	28.26	43.32	12.51	6.26	3.71	2.09	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	311.97	153.85	38.46	34.19	12.82	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	121.14	102.54	27.54	8.32	6.58	3.29	2.88	0.21	0.31
mesothelioma cell line:Mero-25	10850-111F4	324.09	180.66	54.92	29.73	18.16	7.26	6.13	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	106.10	69.43	20.05	14.67	15.89	5.38	1.71	2.44	0.00
mesothelioma cell line:Mero-48a	10852-111F6	168.51	104.96	32.99	25.69	15.72	5.31	2.21	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	573.44	258.60	71.48	41.52	23.92	9.99	3.42	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	297.55	147.41	126.98	27.92	12.60	17.87	5.11	3.92	1.53
mesothelioma cell line:Mero-84	10855-111F9	277.55	124.87	24.27	12.64	15.67	3.54	2.27	2.53	0.76
mesothelioma cell line:Mero-95	10856-111G1	303.73	173.09	0.00	47.21	24.22	0.00	14.70	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	304.46	169.79	29.65	64.60	20.71	5.14	4.14	1.49	0.00
mesothelioma cell line:NCI-H226	10846-111E9	135.56	53.39	9.23	24.25	9.23	2.53	3.26	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	260.33	130.51	30.58	44.07	20.84	5.64	4.44	2.05	0.00
mesothelioma cell line:NCI-H28	10845-111E8	138.17	115.27	42.24	37.92	18.83	3.56	2.54	1.02	0.00
mesothelioma cell line:No36	10857-111G2	195.40	160.17	15.98	31.97	12.72	3.91	3.91	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	199.42	169.62	19.24	27.64	18.15	3.25	1.90	1.35	0.00
migratory langerhans cells, donor1	11901-125F2	213.23	115.35	65.25	16.51	17.66	5.95	1.92	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	231.04	111.49	61.55	14.78	15.51	8.18	0.24	0.61	0.00
migratory langerhans cells, donor3	11903-125F4	175.17	78.43	49.00	20.64	14.90	9.15	0.54	1.62	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	189.03	445.64	89.78	46.03	25.14	10.77	1.96	1.96	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	61.04	231.43	47.90	28.82	34.76	11.02	4.03	1.06	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	234.27	177.61	42.62	12.90	25.57	3.69	1.38	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	107.32	92.29	53.85	6.09	19.22	7.42	1.33	1.14	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	341.50	209.74	390.47	32.15	21.07	66.34	4.44	12.75	0.00
myeloma cell line:PCM6	10474-106I6	201.62	175.13	52.38	23.52	19.57	8.70	4.35	2.17	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	211.54	217.12	69.50	74.57	37.54	13.70	7.10	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.87	51.00	9.02	8.24	10.98	1.18	0.59	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	97.94	69.64	33.76	5.46	7.91	5.57	0.67	1.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	91.48	73.47	31.92	2.79	6.03	6.99	1.25	0.74	0.00
nasal epithelial cells, donor2	12227-129F4	278.75	154.56	114.81	8.28	9.94	3.86	2.21	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	371.09	274.23	78.68	97.55	26.00	10.35	44.86	1.38	0.23
neuroblastoma cell line:NB-1	10539-107G8	237.97	184.84	110.57	66.79	18.15	23.20	7.48	3.93	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	235.35	275.00	142.56	34.37	30.58	14.13	3.37	4.64	0.00
neuroblastoma cell line:NH-12	10555-107I6	514.70	243.56	151.32	71.00	12.86	17.89	11.37	4.10	28.14
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	926.60	247.43	744.89	17.08	12.81	155.15	7.59	24.20	18.50
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	362.22	599.79	142.70	30.25	51.47	22.81	8.39	3.17	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	387.63	276.53	51.12	26.37	25.76	17.31	6.44	4.43	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	576.00	464.75	127.15	7.63	41.96	16.53	1.27	4.45	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	343.89	278.41	39.13	23.69	34.87	8.78	2.40	1.33	0.00
neutrophil PMN, donor1	12133-128D9	238.00	238.00	74.37	0.00	89.25	14.87	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	0.00	39.84	26.56	0.00	26.56	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	47.35	9.47	9.47	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	428.21	280.06	292.07	30.61	46.68	37.54	8.46	3.38	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	307.39	284.18	0.00	77.65	10.41	0.00	5.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	588.31	370.30	98.75	27.57	24.69	19.56	7.37	4.49	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	196.29	133.75	21.28	29.17	8.93	3.68	2.63	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	302.96	142.48	34.03	81.46	17.53	6.84	4.87	2.62	1.22
occipital cortex - adult, donor10196	10172-103C1	465.65	500.67	37.09	96.84	55.63	12.36	24.72	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	369.80	736.66	38.38	82.39	27.10	6.71	4.03	1.34	0.27
occipital cortex, newborn, donor10223	10355-105E4	198.35	204.17	41.13	42.95	12.01	2.55	5.82	2.91	1.09
occipital lobe, adult, donor1	10076-102A4	406.72	577.02	29.91	65.34	64.03	7.08	7.35	3.67	0.00
occipital lobe, fetal, donor1	10073-102A1	402.50	830.31	13.73	47.63	111.57	3.00	21.88	1.29	0.00
occipital pole, adult, pool1	10036-101E9	425.98	232.35	41.71	153.27	33.11	7.73	3.23	3.23	0.39
olfactory region, adult	10195-103E6	310.65	381.53	22.93	92.09	25.60	3.63	7.26	2.29	0.57
optic nerve, donor1	10277-104E7	434.23	338.18	50.03	36.02	36.02	8.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	220.87	170.18	46.93	20.96	22.21	8.77	6.49	2.96	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	166.10	87.93	61.00	33.66	12.36	9.20	2.20	1.65	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	149.68	131.56	35.05	19.81	7.79	7.28	4.23	1.35	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	186.20	109.96	32.57	27.72	23.22	6.47	5.78	1.62	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	283.68	244.58	25.28	30.28	29.10	5.00	1.18	2.06	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	346.64	170.98	210.23	85.02	33.64	27.10	2.80	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	310.67	145.05	142.50	21.84	12.51	28.63	4.67	2.54	25.87
ovary, adult, pool1	10020-101D2	127.45	105.08	44.11	43.50	17.21	9.96	5.68	4.02	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	192.67	262.88	13.20	25.66	42.71	3.12	2.38	0.73	2.57
pancreas, adult, donor1	10049-101G4	408.24	278.43	63.02	29.16	53.62	9.41	3.76	2.82	12.23
pancreatic carcinoma cell line:NOR-P1	10698-109G5	683.74	310.00	50.88	23.76	27.39	3.35	2.52	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	246.50	293.69	62.69	38.50	14.48	4.94	3.75	0.68	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	179.99	112.43	32.45	16.56	16.39	5.63	1.82	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	495.32	228.53	43.75	130.33	27.46	8.97	5.67	2.84	1.01
parietal cortex, adult, donor10258	10373-105G4	495.45	154.88	157.08	22.75	10.28	5.14	5.87	2.94	2.94
parietal lobe - adult, donor10196	10171-103B9	250.17	281.20	43.26	68.66	48.91	15.05	14.11	4.70	0.94
parietal lobe, adult, donor10252	10157-103A4	371.97	633.07	45.61	78.96	23.94	7.70	8.55	1.43	0.00
parietal lobe, adult, pool1	10034-101E7	427.29	218.54	39.65	121.08	26.79	6.87	7.23	2.56	0.35
parietal lobe, fetal, donor1	10072-101I9	341.38	542.14	21.34	26.19	77.59	3.88	13.58	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	193.29	228.43	36.26	31.78	9.72	1.87	11.96	2.99	1.12
parotid gland, adult	10199-103F1	863.33	323.13	86.95	48.72	27.75	15.42	4.93	3.08	1.23
penis, adult	10200-103F2	347.51	232.57	86.48	48.34	18.26	12.89	1.07	4.30	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	205.83	137.78	210.85	14.50	8.37	23.43	4.28	1.67	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	326.94	297.36	0.00	37.73	40.65	0.00	3.06	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	293.49	353.48	138.04	61.92	34.83	23.87	6.45	4.52	9.03
pineal gland, adult, donor10252	10160-103A7	116.67	190.69	52.71	74.62	21.32	15.40	2.37	4.74	1.18
pineal gland, adult, donor10258	10377-105G8	258.98	163.04	118.52	52.67	15.68	11.29	2.51	1.88	63.33
pituitary gland - adult, donor10196	10180-103C9	3619.21	379.43	2510.28	42.50	24.28	312.65	5.06	34.40	199.32
pituitary gland, adult, donor10252	10162-103A9	5245.67	536.81	3352.75	59.94	16.68	476.88	10.94	63.58	283.00
pituitary gland, adult, donor10258	10378-105G9	2960.62	285.17	2346.02	34.05	9.36	193.23	5.11	27.24	324.32
placenta, adult, pool1	10021-101D3	321.11	79.44	65.58	16.56	9.14	13.55	0.65	4.09	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	173.74	144.74	90.32	16.42	11.39	6.75	2.25	1.99	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	74.08	116.26	2.65	35.49	27.39	1.09	2.02	0.78	0.00
pons, adult, pool1	10033-101E6	1002.94	187.71	49.23	101.39	18.50	9.98	7.32	2.58	4.91
postcentral gyrus, adult, pool1	10032-101E5	430.47	255.42	38.44	144.36	30.16	8.72	5.32	1.83	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	899.30	606.50	142.21	75.29	58.56	66.92	0.00	20.91	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	38.56	132.19	71.60	11.02	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	23.47	105.62	23.47	11.74	11.74	0.00	35.21	0.00
prostate cancer cell line:DU145	10490-107B4	213.54	111.14	41.66	50.98	16.31	4.81	2.33	1.46	0.15
prostate cancer cell line:PC-3	10439-106E7	235.04	140.12	60.98	51.36	18.51	13.43	1.45	2.72	7.62
prostate, adult, pool1	10022-101D4	206.41	134.31	49.15	37.46	20.77	8.89	3.45	3.45	0.00
putamen, adult, donor10196	10176-103C5	317.51	179.17	53.35	24.31	13.46	10.15	4.72	2.60	0.47
putamen, adult, donor10252	10152-102I8	231.37	80.39	39.21	21.57	13.73	3.92	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	362.81	54.64	78.68	3.28	4.37	9.84	2.19	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	319.41	59.44	29.72	16.67	9.91	6.04	1.69	1.21	1.93
putamen, newborn, donor10223	10365-105F5	96.71	98.96	11.99	10.50	6.75	2.25	9.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	204.53	54.99	82.63	9.89	4.65	11.93	1.75	4.36	0.00
rectum, fetal, donor1	10067-101I4	548.05	567.52	79.29	27.82	38.95	12.52	8.35	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	133.13	60.00	0.00	16.11	7.63	0.00	1.27	0.00	2.97
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	82.43	57.16	21.12	24.85	4.14	2.49	0.83	1.24
retina, adult, pool1	10030-101E3	428.01	171.96	93.34	60.73	14.61	16.50	5.27	4.77	0.10
retinoblastoma cell line:Y79	10475-106I7	163.94	162.12	98.21	33.25	15.33	21.56	9.09	5.98	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	143.23	48.44	32.95	20.78	12.66	8.98	1.97	2.58	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	316.07	183.91	109.11	35.43	21.93	24.75	4.22	1.69	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	168.24	145.51	51.53	57.60	18.95	3.79	3.03	6.06	0.00
salivary acinar cells, donor1	11771-123I7	195.36	134.50	28.32	14.57	7.77	4.69	4.05	0.81	0.00
salivary acinar cells, donor2	11772-123I8	155.45	137.14	36.07	15.83	10.60	4.68	5.51	2.07	0.00
salivary acinar cells, donor3	11773-123I9	186.04	197.95	95.34	33.76	10.59	10.59	4.63	0.00	0.00
salivary gland, adult, pool1	10093-102C3	2180.28	85.79	203.62	26.88	12.58	23.45	2.86	6.86	54.91
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	50.08	18.21	15.93	25.12	5.14	3.71	2.87	1.26	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.55	25.27	16.46	19.16	7.76	3.64	2.47	1.06	0.12
seminal vesicle, adult	10201-103F3	182.00	118.51	33.33	25.92	11.64	5.82	5.29	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	442.61	281.06	237.09	33.77	19.92	31.09	5.59	6.32	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	254.65	174.13	99.14	25.67	34.22	11.58	4.03	1.76	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	220.78	92.33	109.39	38.13	12.04	15.05	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	366.96	157.42	30.89	21.09	11.01	11.55	4.70	4.43	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	202.93	132.41	22.44	13.48	7.74	2.76	0.99	0.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	141.67	52.77	25.81	10.71	5.29	3.35	1.29	0.65	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	418.51	515.69	90.79	43.98	25.54	7.09	1.42	2.84	0.71
skeletal muscle, adult, pool1	10023-101D5	739.41	333.91	73.76	53.01	28.67	11.63	1.20	4.08	3.48
skeletal muscle, fetal, donor1	10066-101I3	842.20	480.40	132.66	15.08	33.17	21.11	6.03	8.04	554.77
skin, adult, donor1	10074-102A2	196.77	339.26	54.28	0.00	13.57	0.00	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	513.19	320.66	149.60	20.83	22.09	29.04	6.31	5.05	99.73
small cell cervical cancer cell line:HCSC-1	10800-110I8	394.22	342.86	253.48	45.69	89.05	36.69	1.67	4.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	2029.61	932.69	762.80	73.76	20.49	142.16	17.02	19.23	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	134.92	118.54	11.95	56.67	29.49	1.35	3.47	2.31	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	224.16	75.66	0.16	25.88	13.85	0.00	2.80	0.00	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	346.47	340.84	248.03	46.81	20.27	19.95	2.41	3.22	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	190.02	142.08	44.46	40.97	18.31	2.62	1.96	1.53	0.00
small intestine, adult, pool1	10024-101D6	280.33	165.67	51.24	24.01	19.35	6.93	0.96	2.15	0.12
small intestine, fetal, donor1	10064-101I1	232.92	276.41	55.28	24.08	15.48	10.07	2.70	2.21	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	80.53	125.66	25.65	19.49	6.15	2.56	2.05	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	106.23	183.50	30.24	28.69	23.78	3.36	0.78	2.84	0.00
somatostatinoma cell line:QGP-1	10781-110G7	227.28	264.80	64.86	15.55	25.46	8.84	1.34	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	500.79	311.53	53.68	40.83	24.09	11.47	8.49	1.38	8.49
spinal cord, adult, donor10252	10159-103A6	272.05	149.03	44.16	37.46	18.14	6.70	4.34	0.79	3.94
spinal cord, adult, donor10258	10369-105F9	260.12	52.58	52.58	8.99	5.53	7.61	10.38	2.77	6.23
spinal cord, fetal, donor1	10056-101H2	670.21	450.06	105.50	54.89	29.27	23.17	7.32	3.05	45.13
spinal cord, newborn, donor10223	10359-105E8	243.38	108.83	59.24	17.45	3.67	6.43	6.43	0.92	29.85
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	402.81	245.39	42.72	30.92	28.68	6.42	2.54	2.39	0.00
spleen, adult, pool1	10025-101D7	168.51	125.77	64.32	42.40	25.77	10.68	0.77	0.99	0.00
spleen, fetal, pool1	10044-101F8	283.65	123.55	88.75	39.25	18.35	12.00	1.99	2.70	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	211.48	111.59	50.00	13.35	10.97	9.73	1.55	1.86	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	71.39	65.89	30.95	14.62	5.89	4.18	1.71	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	408.86	239.03	116.02	50.32	20.62	16.07	3.15	4.89	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	83.66	70.37	29.32	7.04	10.95	1.56	1.95	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	89.71	75.75	40.86	15.53	7.88	6.75	3.15	1.69	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	513.41	87.26	299.06	12.71	5.93	28.80	2.97	2.12	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	227.61	90.96	73.19	43.58	12.69	6.77	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	269.13	443.21	92.91	28.84	38.45	13.88	5.34	1.07	0.00
submaxillary gland, adult	10202-103F4	1535.29	345.23	145.27	31.90	17.66	18.80	2.28	7.41	58.68
substantia nigra - adult, donor10196	10178-103C7	217.10	379.92	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	217.88	225.57	27.21	26.17	14.12	3.53	6.23	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	1371.23	147.93	128.80	24.83	13.45	19.66	7.76	4.14	36.21
substantia nigra, newborn, donor10223	10358-105E7	219.04	176.64	40.27	16.96	12.72	6.36	5.65	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	252.88	174.01	0.00	60.76	33.93	0.00	6.65	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	352.56	244.48	33.91	126.14	25.18	8.31	3.90	3.56	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	351.86	688.76	17.81	50.57	95.44	4.27	9.97	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	407.89	288.34	21.98	59.34	43.95	6.15	8.79	1.32	0.00
tenocyte, donor1	11763-123H8	459.07	216.44	53.06	68.42	18.85	9.77	4.89	3.84	0.00
tenocyte, donor2	11765-123I1	193.42	140.39	23.65	48.07	20.60	4.96	6.10	4.58	0.00
tenocyte, donor3	11768-123I4	339.16	120.84	34.10	53.01	17.05	9.27	6.30	2.22	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	318.68	98.07	214.83	5.78	5.78	34.33	1.19	7.31	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	330.65	265.91	112.53	21.73	20.04	15.88	3.39	4.01	0.00
teratocarcinoma cell line:PA-1	10807-111A6	264.86	211.39	38.28	13.95	21.85	6.97	0.93	2.01	2.01
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	256.31	155.51	69.44	9.77	14.60	14.35	1.52	4.32	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	219.34	78.28	56.35	12.48	5.67	11.35	2.27	5.67	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	96.63	22.79	25.96	5.02	3.38	5.02	3.82	1.09	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	187.28	81.10	78.49	5.21	3.91	19.22	1.30	2.93	1.63
testis, adult, pool1	10026-101D8	154.40	95.56	76.56	28.13	18.25	13.31	1.40	3.33	0.21
testis, adult, pool2	10096-102C6	202.99	75.78	91.57	10.37	4.96	10.37	2.26	0.90	0.45
thalamus - adult, donor10196	10168-103B6	295.87	302.49	43.06	36.43	38.64	9.94	3.31	0.00	1.10
thalamus, adult, donor10252	10154-103A1	202.70	252.08	30.16	29.54	11.56	3.44	3.75	1.56	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	940.71	117.01	52.35	9.24	9.24	3.08	7.70	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	341.24	334.65	21.57	27.17	24.37	4.12	5.76	0.99	0.33
thalamus, newborn, donor10223	10366-105F6	243.36	266.95	19.56	21.29	8.63	0.00	6.33	0.58	0.00
throat, adult	10209-103G2	462.89	260.16	95.12	33.71	14.98	12.48	2.00	4.24	4.74
throat, fetal, donor1	10061-101H7	848.30	482.04	267.84	26.20	23.77	40.53	7.62	5.48	139.86
thymic carcinoma cell line:Ty-82	10803-111A2	112.48	89.43	60.22	38.95	11.92	12.32	5.17	6.16	0.00
thymus, adult, pool1	10027-101D9	434.64	252.71	104.09	20.78	36.49	12.82	4.08	2.98	0.50
thymus, fetal, pool1	10043-101F7	360.24	173.94	134.14	20.99	22.55	20.05	4.26	3.53	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	211.54	199.18	26.86	33.77	16.49	3.06	3.19	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	214.01	287.76	62.72	41.07	40.09	8.10	6.15	1.40	0.14
thyroid, adult, pool1	10028-101E1	3206.42	238.88	1921.59	27.34	16.33	221.06	4.67	42.92	0.00
thyroid, fetal, donor1	10060-101H6	818.94	425.02	263.14	30.85	29.27	32.69	5.01	5.54	15.82
tongue epidermis (fungiform papillae), donor1	10288-104F9	418.83	461.94	104.71	36.96	30.80	3.08	3.08	3.08	6.16
tongue, adult	10203-103F5	615.17	293.51	72.80	44.42	18.14	8.84	2.56	3.02	24.19
tongue, fetal, donor1	10059-101H5	1352.13	591.14	196.65	21.68	21.68	22.46	1.97	6.70	427.20
tonsil, adult, pool1	10047-101G2	277.89	134.64	88.76	30.85	20.64	14.63	2.50	3.21	4.31
trachea, adult, pool1	10029-101E2	416.44	128.59	60.45	34.85	15.46	13.58	3.03	2.70	7.20
trachea, fetal, donor1	10058-101H4	1079.45	514.34	141.18	27.70	26.16	16.54	2.31	5.00	108.10
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	123.29	133.56	14.53	18.07	21.61	3.54	2.83	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	368.99	126.14	62.92	51.06	14.89	10.54	2.94	1.52	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	145.09	76.93	14.10	39.02	13.63	3.76	6.11	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	251.13	224.50	53.27	76.10	41.86	13.32	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	201.38	213.66	30.90	31.49	29.12	4.32	6.18	1.44	0.00
umbilical cord, fetal, donor1	10057-101H3	383.92	308.80	43.82	31.30	27.12	6.26	2.09	4.17	8.35
uterus, adult, pool1	10100-102D1	214.99	57.33	61.26	30.37	12.46	7.34	2.05	3.24	0.17
uterus, fetal, donor1	10055-101H1	390.09	364.49	86.00	39.42	32.76	15.36	5.12	4.61	2.56
vagina, adult	10204-103F6	189.34	227.46	76.90	34.25	39.42	7.75	0.00	0.00	0.00
vein, adult	10191-103E2	233.88	217.23	69.71	34.63	23.67	8.33	1.97	1.32	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	212.56	104.14	44.60	14.95	16.29	7.48	1.07	0.80	0.00

Property "Nearest transcripts" (as page type) with input value "BC108315:-36 ENST00000354359.12:-77 ENST00000371085.8:-77 NM_001309842.2:-77 NM_001077489.4:-77 NM_080426.4:-77 NM_000516.7:-77 NM_001077488.5:-77 BC089157:-87 BC008855:-87 BC104928:87 AK225818:-105 AK026564:-112 ENST00000265620.11:-134 X04408:152 ENST00000468895.6:181 ENST00000371095.7:-196 X04409:205 ENST00000371081.5:206 X07036:206 AB385065:213 EU832170:215 EU832264:215 CU678144:216 CU679149:216 KJ905761:216 HQ448266:216 KJ891258:216 KR710750:216 KR710751:216 KR710752:216 KR710753:216 ENST00000338783.7:217 KU178095:217 KU178096:217 BT009905:217 AF064092:217 AF088184:217 AF493897:217 AF493898:217 BC066923:217 ENST00000682803.1:244 M14631:250 LF350859:251 MA586436:251 AK315860:295 BC022875:329 LQ980482:-438 ENST00000488652.6:471" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.